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Summary 
Guidance of experiments and investigation of experimental outcomes through computational 
models is increasing in both scope and importance. Few modern research topics can be tackled 
with laboratory experiments alone as these rarely achieve the desired resolution or would be 
combinatorically too vast to apply exhaustively. This thesis presents four cases in which 
computational models either provided an interpretation of experimental outcomes or guided 
experiments in order to efficiently achieve the intended outcome. The significant difference in 
function of the target molecules presented herein underlines the strength of computer-based 
models to aid and guide a large variety of experiments. 
The first case is the molecular dynamics analysis of medium-sized organic molecules known 
as cavitands, which display two distinct conformations (an opened kite and a closed vase 
conformation) as a function of the physiochemical environment. High precision inter-dye 
distance distributions as well as relative dye-dye angles (κ²) were obtained from molecular 
dynamics simulations. By incorporating these distances and κ² values into a simple Markov 
state model, a Förster Resonance Energy Transfer (FRET) experiment was emulated, giving 
modeled fluorescence anisotropy decay and donor fluorescence decay curves that highly 
correlated with experimentally determined FRET signals.  
The cytochrome P450 3A4 variant (CYP3A4) is the most abundant cytochrome P450 in the 
human liver. Its high promiscuity leads to CYP3A4 processing nearly every xenobiotic entering 
the human body. We set out to model the binding behavior of the anticonvulsant carbamazepine 
(CBZ) for which no X-ray crystal structure or NMR ensemble in complex with CYP3A4 is 
available. Utilizing molecular dynamics simulations in conjunction with cluster analysis 
implemented in the program WORDOM, we proposed target residues for mutational studies. 
Compared to the wild type, one mutant (A370V) displayed a significantly higher turnover rate 
at high substrate concentrations while another mutant (I369F) saw increased turnover at low 
substrate concentrations. Further, the kinetics of CBZ epoxidation of the A370V mutant 
differed from the standard Michaelis-Menten kinetics of wild-type CYP3A4. Its sigmoidal 
kinetic profile indicated induced cooperativity, which was likewise observed for two other 
proposed mutants (S119A, A370L). In addition, all single-point mutants (A370L, A370V, 
I369F, I369L, and S119A) showed increased spin-shift fractions in comparison to wild-type 
CYP3A4, indicating a shift of the spin equilibrium towards the ferric high-spin state. Finally, a 
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single simulation showed the egress of a CBZ molecule via a channel previously hypothesized 
in the literature.  
The importance of epigenetics in the time-dependent development of cells and its implication 
in cancer has recently come to light. Resultant efforts to disrupt the action of epigenetic reader 
molecules called bromodomains, which provide an interface for large protein complexes to 
interact with chromatin, have led to a series of chemical probes and drugs. The SMARCA4 
(SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A, 
member 4) bromodomain has been indicated as a potential target for certain SWI/SNF-mediated 
cancers. Applying an established virtual screening scheme, Anchor-based Library Tailoring 
Approach (ALTA), in combination with the novel docking software rDock and an interaction 
energy-based scoring scheme, we identified a trans-glycoluril-containing compound out of a 
multimillion molecule database (ZINC). This compound was verified in vitro by an ALPHA 
screen assay, resulting in an IC50 value of 20 µM.  
Actin is the most abundant protein in higher organisms and is the primary subunit of actin 
filaments, which are crucial in maintaining stability and motility of the cell its components. A 
series of natural products extracted from deep sea sponges has been identified as altering the 
dynamics of actin polymerization. The two primary sites of interference with actin 
polymerization are the barbed end and, with the characterization of the natural product 
latrunculin, the inter-domain region between subdomains 2 and 4. Recently, iriomoteolide 3a 
was shown to impact the dynamics of actin polymerization, though its mechanism was 
unknown. A 7 µs molecular dynamics simulation of actin with iriomoteolide 3a is presented 
herein. These simulations were investigated for the interaction frequency of iriomoteolide 3a 
with each actin residues in order to identify preferred interaction hot spots. Following the 
identification of the barbed end as the most likely site of association, two putative binding 
modes of iriomoteolide 3a with monomeric actin are presented while simulations of the natural 
product reidispongiolide A support its mechanism of actin filament severing as proposed in the 
literature. 
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Zusammenfassung 
Die Anleitung von Experimenten und die Auswertung experimenteller Resultate durch 
computergestützte Modelle breiten sich ständig aus, sowohl in ihrem Umfang, als auch in ihrer 
Wichtigkeit. Wenige moderne experimentelle Fragestellungen können heute noch 
ausschliesslich mit Laborexperimenten untersucht werden, da diesen entweder die nötige 
Auflösung fehlt, oder sie kombinatorisch zu anspruchsvoll sind, um sie umfangend einzusetzen. 
Diese Dissertation präsentiert vier Anwendungsfälle, in denen computerbasierte Modelle 
entweder die Interpretation der experimentellen Daten ermöglichten, oder Experimente 
anleiteten,  um das vorher gesetzte Ziel effizient zu erreichen. Die signifikanten Unterschiede 
in den Funktionen, der hier präsentierten Zielmoleküle, betont die Stärke von 
computerbasierten Modellen, eine grosse Auswahl an Experimenten zu leiten und zu 
unterstützen. 
Der erste Anwendungsfall ist die molekulardynamische (MD) Analyse von mittelgrossen 
organischen Molekülen, die Cavitanden genannt werden, und zwei verschiedene konformelle 
Zustände aufweisen (eine offene Drachen- und eine geschlossenen Vasenform),  welche eine 
Funktion der physikochemischen Umgebung sind. Hochpräzise Distanzverteilungen, ebenso 
wie relative Farbstoff-Farbstoff-Winkel (κ²), wurden mit Hilfe von MD Simulationen 
bereitgestellt. Durch den Einarbeitung dieser Distanzen und κ²-Werte in ein einfaches Markov-
Modell, wurde ein Förster Resonanz Energie Transfer (FRET) Experiment emuliert, welches 
modellierte Fluoreszenzanisotropiezerfall- und Donorfluoreszenzzerfall-Kurven generierte, 
welche stark mit denen, im Labor durchgeführten, FRET-Experimenten korrelierten. 
Die Zytochrom P450 3A4 Variante (CYP3A4) ist das am häufigsten vorkommende Zytochrom 
P450 in der menschlichen Leber, dessen hohe Promiskuität zur Umsetzung von fast allen 
Fremdkörperstoffen führt, die in den menschlichen Körper gelangen. Wir begannen mit der 
Modellierung des Bindeverhaltens von Carbamazepine (CBZ), einem Antikonvulsivum, für 
welche weder Röntgen-Kristall-Strukturen, noch Nuclear Magnetic Resonance (NMR) 
Ensembles im Komplex mit CYP3A4 vorhanden sind. Durch die Verwendung von  
Moleküldynamiksimulationen in Kombination mit Clusteranalyse, implementiert im Programm 
WORDOM, schlugen wir Aminosäuren für nachfolgende Mutationsstudien vor. Im Vergleich 
zum Wild-Typ, wies eine Mutante (A370V)  eine signifikant höhere Umsatzrate bei höheren 
Substratkonzentrationen auf, während eine andere Mutante (I369F) eine höhere Umsatzrate bei 
niedrigeren Substratkonzentrationen zeigte. Weiterhin wich die Enzymkinetik der CBZ-
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Epoxidierung der A370V-Mutante merklich von der der Standard-Michaelis-Menten-Kinetik 
ab, welche das Wildtyp-CYP3A4 zeigt. Das sigmoidale Kinetikprofil wies auf eine induzierte 
Kooperativität hin, welche weiterhin für zwei andere Mutanten beobachtet wurde (S119A, 
A370L). Zusätzlich zeigten alle Einpunktmutanten (A370L, A370V, I369F, I369L, S119A) 
erhöhte spin-shift Fraktionen im Vergleich zu Wildtyp-C3A4, welche auf einen hoch-spin 
Eisenzustand hinweisen. Zuletzt zeigte eine Simulation das Verlassen eines CBZ-Moleküls, 
durch einen Kanal, welcher bereits früher in der Literatur postuliert wurde.  
Die Gewichtigkeit epigenetischer Prozesse in der zeitabhängigen Entwicklung von Zellen und 
deren Implikationen in Krebs, rückten erst kürzlich in das Rampenlicht. Die darauf 
zurückzuführenden Bestrebungen epigenetische Lesemodule, sogenannte Bromodomänen, 
welche in grossen Proteinkomplexen die Interaktion mit Chromatin ermöglichen, zu stören, 
führten zu einer Serie chemischer Sonden und Medikamente. Die SMARCA4 (SWI/SNF 
related, matrix associated, actin dependent regulator of chromatin, subfamily A, member 4)-
Bromodomäne wurde als potentielles Ziel für bestimmte SWI/SNF Krebsarten identifiziert. 
Durch die Anwendung einer etablierten virtuellen Screeningmethode, Anchor-based Library 
Tailoring Approach (ALTA), in Kombination mit dem neuen Dockingprogramm rDock und 
einem interaktionsenergiebasiertem Bewertungsschema, haben wir einen trans-glycoluril 
beinhaltenden Stoff aus einer multi-Millionen grossen Datenbank (ZINC) identifiziert. Dieser 
Stoff wurde in vitro durch eine ALPHA Screen Prüfung auf 20 µM IC50 verifiziert.  
Actin ist das, in höheren Lebewesen, am häufigsten auftretende Protein und ist die primäre 
Untereinheit von Acinfilamenten, welche unabdinglich sind, für die Instanthaltung und 
Bewegungsleistung der einzelnen Zellbestandteile. Eine Serie an Naturstoffen, welche von 
Tiefseeschwämmen extrahiert wurde, weist verändernde Eigenschaften von 
Actinpolymerisierungen auf. Die zwei primären Interaktionsstellen für Interferenz mit 
Actinpolymerisierung sind das "barbed end" und, seit der molekularbiologischen 
Charakterisierung von des Naturstoffes Latrunkulin, auch die Interdomänenregion zwischen 
den Unterdomänen 2 und 4. Erst kürzlich wurden Einflüsse von Iriomoteolide 3a auf 
Actinpolymerisierung nachgewiesen. Es wird eine7 µs MD-Simulationsserie von Iriomoteolide 
3a mit monomerischem Actin präsentiert. Diese Simulationen wurden auf die 
Interaktionsfrequenz von Iriomoteolide 3a mit jeder Aminosäure überprüft. Nachdem das 
"barbed end" als der wahrscheinlichste Hauptinteraktionspunkt identifiziert wurde, erfolgte die 
Präsentation von zwei möglichen Bindeposen. Simulationen mit dem Naturstoff 
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Reidispongiolide A bestärken den vermuteten Interaktionsmechanismus mit dem 
Actinfilament. 
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Chapter 1  
Introduction 
 
1.1 Computer-based simulation as an aid to experimentalists 
 
The investigation of biomolecular processes is located at the very basis of research which leads 
to improved conditions of human life. With each piece of knowledge gained on biological 
pathways and the intricacies of cells, the chance to develop a cure for a related disease increases. 
Today, few experiments can be conducted without the support of computer-based modelling. If 
the experimental observables can be compared or coupled to the parameters of modeled 
systems, the former might be explained on the level of detail of the latter1. In the field of 
biomolecular research, molecular simulations have become an important tool to facilitate and 
extend the insights gained from experimental properties such as X-ray diffraction intensities, 
NMR parameters, quantities derived from EPR, CD infrared, RAMA or fluorescence 
spectroscopy2–6. With increases in computational resources, the scope of simulations grows 
proportionately to the complexity of simulations as well as the breadth of natural phenomena 
they aim to explain. Studies of polypeptide, folding into their native protein conformation, as 
well as aggregation of proteins into oligomers and lipids into micelles are now among the most 
commonly performed simulation studies7,8.  
With the development of force fields for small organic compounds, high-resolution 
investigations into protein substrate interactions can be conducted on relevant time scales. 
Simulations which model the unbinding of small molecular fragments have been shown to be 
in agreement with experiments and can be applied as a metric to identify potent from inactive 
small molecular inhibitors9. The most attractive property to be obtained from molecular 
simulation of biomolecules and small organic compounds is the estimation of biding free 
energies by molecular dynamics simulation10. Although the accuracy of this method is highly 
dependent on sampling time, simplified models have provided acceptable results11,12.  
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1.2 Molecular dynamics simulations 
 
Molecular dynamics simulations in particular have become a very important tool to facilitate 
the interpretation of experimental biological data on an atomistic level1. Its significance was 
most recently recognized by awarding the 2013 Nobel Prize in chemistry to Martin Karplus, 
Michael Levitt, and Arieh Warshel “for the development of multiscale models for complex 
chemical systems”13. Molecular dynamics simulations represent atomic motions in terms of 
classical ball-on-a-spring mechanics in which the bonded energy is generally approximated by 
the sum of following terms:  
 
                                       =	∑ 	( − )                                           (1) 
 
where Ebond is the bond energy calculated over all covalent bonds n with a harmonic potential 
kb and the difference between given bond length r and equilibrium bond length r0. 
 
                             =	∑ 	( −	)²                                       (2) 
 
in which the angle energy Eangle is the sum over all products of the stiffness term kθ and the 
difference between current angle θ and reference angle θ0 squared. 
 
                             =	∑ [1 + cos	("# − 	$)]&                              (3) 
 
where torsional energy term Etorsion is expressed as a periodic function in which ϕ, A, and n 
are empirically determined values describing shift, amplitude, and periodicity of the cosine 
function for each every dihedral τ of four consecutively bonded atoms. Additional to these 
covalent parameters, non-covalent parameters play a crucial role in determining the correct 
interaction between atoms. As atoms in molecular dynamics simulations are approximated as 
point charges with a van der Waals radius, the non-bonded interactions are represented by:  
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where the electrostatic contribution to the total energy of a system ECoulomb is modelled as a 
Coulomb potential in which qi and qj are two point charges at distance rij while ε0 is the 
dielectric constant of vacuum. 
 
 12 =	∑ ∑ (
3/0
/0
45 	− 	
6/0
/0
7 )*                                         (5) 
  
the Lennard-Jones potential used to describe the van der Waals (vdW) contributions to the 
energy of the system contains an attractive term 1/r6 and a repulsive term 1/r12 while Bij and 
Aij describe the location and depth of the minimum of the potential for two non-covalent 
atoms i and j. 
 
                          V = Ebond + Eangle + Etorsion + ECoulomb + Evdw                (6) 
 
Summing over all terms, Ebond, Eangle, Etorsion, ECoulomb, Evdw describes the potential energy V as 
a function of atom positions. 
To propagate the system through time, Newton’s equation of motion is then solved for the 
system of N interacting atoms: 
 
    8
9²/
9²
= 8: = ; , = = 1…?                                (7) 
Where mi and ai are the mass and acceleration of atom i while the force Fi acting on atom i is 
the negative gradient of the potential energy: 
 
                            ; =	−
9@
9/
                                                                                 (8) 
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Over the years, a variety of force fields have been generated for proteins, nucleic acids, and 
sugars out of which CHARMM, AMBER, OPLS and GROMOS represent the most prominent 
ones14–18. Biomolecules like proteins and nucleic acids provide an intrinsic advantage for the 
parameterization effort as they are made up of a small amount of subunits like amino acids or 
nucleic bases which can be relatively easy parameterized to create an accurate description of 
the whole system as a combination of its subunits. However, more and more emphasis is put on 
the interaction of small organic molecules with their respective protein or DNA target. The 
combinatorial complexity of small organic compounds provides a greater challenge as 
exhaustive ab initio parametrization would take considerable amounts of time and resources. 
Thus, in the past some atomic force fields for small molecules were derived for a simplified 
view of molecules where for instance distinctions between carbon atoms were only made based 
on the number of bonds they provide with their immediate neighbors and if they are in an 
aromatic system or not, exemplified by the TRIPOS Atomic Force Field19. However, to provide 
more accurate parameters, a series of more complex force fields were developed. The Merck 
Molecular Force Field (MMFF94) was one of the most wildly applied force fields due to its 
ability to reproduce properties of small molecules in condensed phase20. Subsequently, efforts 
have been made to generate small molecular force fields for other protein force fields such as 
the General Amber Force Field (GAFF) and the OPLS-AA force field21,22. Most recently a 
general force field for CHARMM (CGenFF) was developed with the clear goals to provide 
CHARMM-consistent parameters and an ongoing parametrization effort in order to obtain the 
means to accurately predict the interaction of small molecular ligands and their protein targets23. 
CGenFF provides a series of explicitly parameterized fragments which represent the basis to 
parameterize novel molecules as analogues to these parameterized fragments via programs like 
Paramchem and MATCH24–26. This enables the large-sale parametrization of small molecules 
for both simulation of complexes and evaluation of docked poses which in turn enables models 
of higher precision to be applied in the field of docking-based drug development.  
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Figure 1: Schematic overview of the contemporary drug discovery process (top) and the number of ongoing 
projects (bottom gray upper) with the associated costs (bottom gray lower) in million US dollars27.  
 
1.3 Computer-aided drug discovery 
Rational drug design describes the directed discovery and optimization of small organic 
molecules towards potency against a specific target with little side effects. The drug design 
process starts from initial target and hit identification (Figure 1). Subsequently, the hit molecule 
is further optimized into a lead structure of higher potency compared to the initial hit. In the 
next step, enhancement of properties of adsorption, distribution, metabolization, excretion and 
toxicity (ADMET) is emphasized. Molecules displaying high potency towards the target and 
simultaneously exhibit favorable metabolic properties are then studied in clinical trials, to be 
assessed for their applicability as a drug (Figure 1) which is then finally commissioned to the 
market.  
In technical terms, the identification of small molecule inhibitors can be considered as an 
optimization and a combinatorial problem, dealing with the selection of a handful of active 
compounds from what is now considered to be a chemical space with a size that ranges between 
1027 to 10100 synthetically available drug-like molecules28–30, a number far too large for any 
chemist to synthesize and evaluate exhaustively. With the explosion of computational resources 
in the last decades, in silico modelling and evaluation of the interactions between a vast number 
of molecules and their designated target has become a feasibly and widely applied task called 
virtual screening. The aforementioned hit identification is the very basis of any virtual screening 
and describes the determination of a heterogeneous series of molecular scaffolds exhibiting 
homogeneous effects on the target protein. These effect are usually the displacement of the 
natural substrate/ligand of the target protein or other interference with the target function. There  
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Figure 2: Overview of the ALTA procedure31. Beginning at the decomposition stage (dark blue arrow) a library 
of fragments is generated which is then filtered according to certain criteria like the Rule of Three for fragment-
based design32. The fragments are then docked and looked up in larger molecules which contain them. The 
resulting parent molecules are then subjected to flexible docking and finally filtered to criteria resulting from the 
docking stage.  
are a multitude of inhibition mechanisms by which this interference is achieved. Competitive 
inhibition takes place by direct displacement of the substrate via an inhibitor of higher potency. 
Allosteric inhibition, in which the inhibitor binds to a peripheral or secondary binding site 
which causes the displacement of the natural ligand in the active, site is a common form of non-
competition-based inhibition. Additionally, there are uncompetitive inhibition mechanisms 
where the inhibitors achieves inhibition at the level of the protein-substrate-complex33.  
Once a promising scaffold is identified, its potency and optimizability towards more drug-like 
properties are investigated or created in what is considered lead identification. Metrics like the 
ligand efficiency (LE) and the ligand lipophilic efficiency (LLE) guide this selection process. 
Finally, a lead structure is further optimized into a drug candidate which is then ultimately 
assessed for its in vivo properties and goes into clinical trials (EIH, Entry Into Humans). If all 
clinical trials are passed, the compound is finally licensed and enters the market as a drug. The 
costs of the entire process are currently reported to exceed 800 million USD in 2004 towards 
2.6 billion USD in 201427,34,35.  
The virtual design of a ligand can incorporate the presence of structural information of the 
protein (structure-based design) or by predicting the binding properties of a novel molecule by 
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inference from known properties of established ligands (ligand-based design). Lipinski’s Rule 
of Five is probably the most widely applied ligand-based descriptor framing the upper and lower 
limits of xenobiotics absorption in humans36. Today, both methodologies are applied to ensure 
maximum success of the development at each step of the design process37. A particularly 
successful virtual screening scheme is fragment-based design38. Fragment-based design starts 
from small, weak-binding fragments which are subsequently extended into larger molecules. 
The way these fragments are generated can be different, depending on what the goals and 
restrictions of the drug design. Molecular fragmentation rules like RECAP have been devised 
to enable the chemical feasibility of the full molecules by ensuring that fragments satisfy retro-
synthetic rules while other fragmentation approaches aim at the combinatorically largest set of 
fragments39–41. If the goal is de novo design in order to investigate chemical space not yet 
purchasable, fragments can be generated entirely by combinatorial enumeration of all possible 
structures42.  The two main ways to extend fragments into larger molecules are growing and 
linking43. Growing extends the original fragments into other parts of the protein-ligand-
interaction interface (now referred to as binding pocket) by ensuring that each addition to the 
fragment results in a larger structure with higher potency and specificity. Linking combines 
fragments which were placed in different parts of the binding pocket by a series of linker 
molecules43. The linking step is subject to a quality check similarly to the growing step, as only 
linkers providing favorable energy with the receptor are accepted into the molecule. A special 
case of fragment-based design is the so called anchor-based library tailoring approach 
(ALTA)31. The ALTA approach (Figure 2) exploits the fragment stage in order to reduce 
chemical space of commercially available compound libraries by identifying fragments with 
preferred binding properties. Depending on the amount of fragments simultaneously required 
in a larger molecule, the ALTA approach can be considered either a growing or linking scheme. 
Two prime advantages of this approach are the bypassing of the need for dedicated linking or 
growing software while ensuring that the resulting molecules are all chemically feasible. 
However, the prime disadvantage of this method is its inability to provide de novo-generated 
molecules as the chemical space which is screened is identical to the chemical space the 
fragments were generated from.  
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1.4 Structure of the thesis 
 
The thesis is organized in the following manner: chapter 2 presents the experimental and 
computational studies performed on the cavitand system where a close correlation between 
simulation and experiments is highlighted. These studies resulted in respective highlighted 
publication. Chapter 3 deals with the published study of molecular dynamics simulations 
performed on CYP3A4 in complex with CBZ and the subsequent suggestion of mutants and 
their in vitro verification. Chapter 4 is a manuscript in preparation based on the virtual screening 
performed on SMARCA4 which resulted in the in vitro verified trans-glycoluril scaffold with 
an IC50 value of 20 µM.  Chapter 5 is a regular thesis chapter not yet published on the 
identification of the putative site of interaction of iriomoteolide 3a and its target, monomeric 
actin as well as simulations of bound and unbound reidispongiolide A supporting its proposed 
mode of interaction with F-actin.  
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Introduction 
With the increased recognition that proteins involved in epigenetic regulation are a promising 
target for drug development against developmental diseases such as cancer, efforts to find small 
molecule inhibitors against epigenetic targets have been increased significantly1–3. A prime 
focus of research in this area has been the role and subsequent interference of bromodomains 
(BRD)4–7. Bromodomains have been identified as an interface for histone recognition in larger 
protein complexes8. SMARCA4/BRG1 is one of two mutually exclusive helicases of the 
SWI/SNF chromatin remodeling complex. In addition to SWI/SNF, SMARCA4 was also 
identified as being part of WINAC, NUMAC, NCoR and mSin3A/HDAC complexes9. The 
helicase domain represents the central catalytic domain of these complexes and is speculated to 
be involved in the transcription and repression of a multitude of genes, in a contextual manner. 
As part of SWI/SNF, SMARCA4 is crucial in early embryonic development and 
spermatogenesis. Mutations inactivating SMARCA4 which mostly occur in the helicase 
domain have been identified in several ovarian, breast, lung, pancreas and prostate cancer lines 
well as Coffin-Syris syndrome10–16. Contrary to the detrimental effects of loss of SMARCA4 
activity in mutated genes, inhibition of functional SMARCA4 becomes significant as a tumor 
suppressor mechanism in the context of SWI/SNF mediated cancers17. Wang et al. (2009) have 
shown that upon loss of the SNF5 subunit of SWI/SNF, oncogenesis is dependent on the 
retained activity of SMARCA418. Further, investigations into Wnt-dependent tumorourigenesis 
indicated that loss of SMARCA4 functionality slows aberrant Wnt-signalling in mice19. In 
addition to the helicase, SMARCA4 also contains a class VIII bromodomain which acts as the 
recognition module for acetylated lysines (Kac) which loses the capacity for binding upon 
mutation of the conserved ASN154020.  
As of today, there is a total of three structures available for the SMARCA4 
bromodomain, two crystal structures (PDB-ID: 3UVD, 2GRC) and one NMR ensemble (PDB-
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ID: 2H60). Out of these structures only 3UVD contains a fragment-sized ligand namely 1-
methylpyrrolidin-2-one (PDB ligand identifier MB3). The complex features a single hydrogen 
bond between the MB3 carbonyl oxygen and the side chain amide of Asn1540 at a distance of 
2.5 Å and an H-bond angle of 155°. Molecular dynamics studies conducted for series of 
bromodomains including SMARCA4 assessing the χ2 and χ1 dihedral dynamics of its 
conserved asparagine (Asn1540) and the N-adjacent Phe1539 respectively showed several 
rotational events for both residues within a single 0.5 µs simulation. The study also showed a 
change of binding site accessible molecular surface (SASA) upon the change of Phe1539 χ1. 
Small molecules with low µM Ki values for SMARCA4 have been primarily identified only in 
the context of a bromoscan or selectivity panels for a series of molecules designed specifically 
for BRD4(1) or BRPF1 (Figure 1a-c)21,22. Additionally, thermal shift data for a series of 2-
thiazolidinones derivatives, RVX-208 derivatives as well as dual kinase-bromodomain 
inhibitors showed ∆T values below 1°C at 10 µM and 50 µmol of compound respectively23–25. 
However, to this day PFI3 is the only dedicated chemical probe reported for SMARCA4 , albeit 
not published in the scientific literature (Figure 1d)26. The Structural Genomics Consortium 
(SGC) reported estimations of PFI3 dissociation constants (KD) via isothermal titration 
calorimetry (ITC) at 89 nm for SMARCA4. Thermal shift experiments are reported as showing 
a 5.1° shift for SMARCA4 in the presence of 10 µM PFI3.  
Here we report the identification of a ligand of the SMARCA4 bromodomain by an in silico 
fragment-based approach27. To our knowledge SMARCA4 has not yet been directly targeted 
by any virtual screening campaign. 
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Methods 
Selection and preparation of SMARCA4 structure for docking 
At the start of this project, three structures of the SMARCA4 bromodomain were available at 
the RCSB protein databank (PDB-ID: 3UVD, 2GRC, 2H60)28. The only structure containing a 
small-molecule ligand (3UVD) was chosen for this study29. Except for four structural waters in 
the Kac binding site (numbered 2, 4, 19, and 58 in 3UVD), all water molecules and 1-
methylpyrrolidin-2-one were removed. The amino group of the N-terminal Leu1458 was 
considered as positively charged and the carboxyl group of the C-terminal Lys1563 as 
negatively charged. Coordinates of hydrogen atoms and missing atoms of the Lys1460, 
Lys1461, Lys1473, Lys1492, Glu1493, and Leu1541 side chains were generated by the psfgen 
module of VMD30. The CHARMM36 and TIP3P parameters were used for SMARCA4 and the 
four water molecules, respectively30,31. The coordinates of the hydrogen atoms were minimized 
in CHARMM first by 2,000 steps of steepest descent followed by the conjugate gradient 
algorithm (20,000 steps) using as convergence criterion a gradient of the energy of  0.01 
kcal/(mol Å)33–35.  
Library generation: 
The ZINC 12 all-purchasable library (version 12 of 01 2012, containing 22,724,825 molecules) 
was downloaded from http://zinc.docking.org/ with protonation states at neutral pH36. The 
molecules were automatically decomposed by the program DAIM which cuts at rotatable 
bonds37. The program MATCH was used to generate CHARMM General Force Field (CGenFF 
v.2b6) parameters for all fragments including 1-methylpyrrolidin-2-one from the 3UVD 
structure (which is a positive control for docking)38,39. As further controls, a library of known 
bromodomain inhibitors was assembled by merging the ChEpiMod database with remaining 
published inhibitors and patented structure not available in the ChEpiMod at the time40. 
ChEpiMod contained a multitude of molecules tested for the BAZ2B bromodomain labeled as 
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inactive/inconclusive at a given concentration, these molecules were removed from the 
database. 
Fragment docking and fragment selection: 
All rigid fragments (no rotatable bonds or a single hydroxyl group) were docked by SEED (v. 
3.3.6.) with MATCH-generated CGenFF atom types. The dielectric constant of the solute was 
set to 2.0, and default geometric parameters were used38,39,41. The binding site used for docking 
included Val1484, Phe1485, Ile1486, Gln1487, Leu1488, Pro1489, Tyr1497, Ala1536, 
Phe1539, N1540, and Ile1546  as well as waters  2, 4, 19 and 58. All fragments were docked 
on Xeon 5560 processors clocked at 2.8 GHz each. The co-crystallized 1-methylpyrrolidin-2-
one was evaluated for its total SEED energy using the pose as in the X-ray structure, i.e., without 
prior minimization of the complex. The calculated total SEED energy of 1-methylpyrrolidin-2-
one was then set as the lower boundary for fragment filtering at -8.16 kcal/mol. 
All fragments with a lower total SEED energy were then evaluated for hydrogen bonds with 
the SMARCA4 binding site residues as defined for SEED docking. The criteria for hydrogen 
bonds were a distance between donor and acceptor heavy atoms lower than 3 Å and the 
hydrogen bond angle (donor-H ••• acceptor) deviating by a maximum of 30 degrees from the 
optimal angle of 180°.  
Substructure search: 
All fragments were looked up in larger molecules via RDKit module 
HasSubstructMatch(MolFromSmarts([SMARTS]))42. SMARTS patterns with explicit 
hydrogens involved in hydrogen bonding were searched in the ZINC all-purchasable library. 
The resulting molecules were then evaluated for their purchasability. Furthermore, all 
remaining molecules were filtered for containing reactive, unwanted chemical moieties 
(Supplementary 1) derived from lists provided by Hann et al. 1999 and Brenk et al. 200743,44.  
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Tethered docking: 
The minimized SMARCA4 structure from the fragment stage, including the four water 
molecules, were split into individual pdb files and served as the receptor and structural waters. 
To keep the original fragment in place, the anchor fragments where tethered via sdtether 
supplied with rDock45,46. The SMARTS pattern required for the previous substructure search 
was supplied to sdtether along the mol2 (TRIPOS atom types) files of the respective molecules 
and the fragment mol2 file containing its docked coordinates47. Tethered docking was 
performed on Xeon 5560 clocked at 2.8 GHz each. In the LIGAND section of the rDock 
parameter file, translation and rotation (TRANS_MODE, ROT_MODE) were kept tethered with 
a maximal translation and rotation of 1 Å and 30° respectively. The dihedrals were allowed to 
freely rotate (DIHEDRAL MODE FREE) to account for eventual accommodation of hydroxyl 
groups. The structured waters in the SOLVENT section were also treated as TETHERED in both 
rotation and translation with maximal values similar as for the LIGAND section. The 
OCCUPANCY was set to 1 Å. The site mapper was set to RbtSphereSiteMapper with a center 
at (6.049, 14.390, 44.171), the GRIDSTEP was set to 0.5 Å with a radius of 11.0 Å. The small 
sphere for site mapping was set to a radius of 1 Å while the large sphere setting 
(LARGE_SPHERE) was set to a radius of 7 Å. A single cavity (MAX_CAVITIES 1) was chosen. 
After docking, all conformations having a positive energy (<SCORE>) were discarded from 
further evaluation. 
CHARMM minimization and calculation of electrostatic solvation: 
Following docking in rDock, non-polar hydrogens were added in openbabel (version 2.3.2)48. 
All poses obtained from rDock for each molecule were evaluated for the number of hydrogen 
bonds it formed with SMARCA4 residues. Subsequently, the 36 molecules featuring four 
hydrogen bonds were parameterized for CGenFF through Paramchem49,50. Due to upload 
restrictions of the Paramchem web service, molecules featuring conformations with two and 
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three hydrogen bonds (a total of 4198 and 159,220, respectively) were parameterized for 
CGenFF via MATCH38. The generated rtf(topology), prm(parameter), and str(stream) files 
were supplied to psfgen module from VMD in order to generate psf files and pdb files for the 
respective molecules, containing the docked coordinates and individual parameters necessary 
for processing in CHARMM. The docked molecules were then minimized in the receptor by 
CHARMM using first the steepest descent algorithm (500 steps) followed by the conjugate 
gradient algorithm (10,000 steps) with a convergence criterion of 0.01 kcal/(mol Å). After 
minimization the intermolecular van der Waals energy (∆Evdw) and Coulombic energy 
(∆ECoulomb) were evaluated. The electrostatic solvation energies (for the complex, ligand, and 
protein individually) were calculated by the finite-difference Poisson module in CHARMM 
using dielectric constants of 2.0 and 78.2 for the solute and solvent, respectively51. The 
electrostatic contribution to solvation energy of the binding process (∆Esolv) was then 
approximated as the sum of the electrostatic solvation energies of the complex, receptor, and 
ligand. The electrostatics component of the free energy of binding (∆Gelec) was calculated as 
the sum of ∆ECoulomb and ∆Esolv. Additionally, ∆Elect was calculated as a measure of how much 
the ligand-bound state is electrostatically favorable compared to the ligand in solvent. ∆Elect 
is computed as the difference between intermolecular electrostatic interaction of the ligand in 
solvent (Einter,solv ) calculated by the finite-difference Poisson module in CHARMM using 
dielectric constants of 78.2  and the electrostatic free energy of solvation of the ligand 
(∆Esolv,lig).  Finally, the total interaction energy Etotal was calculated as the sum of ∆Evdw and 
∆Gelec. Following, all molecules with a positive Etotal were discarded. All 15 molecules featuring 
4 and 3 hydrogen bonds before energy minimization where visually inspected after energy 
minimization. Molecules featuring 2 H-bonds had all molecules removed which had a positive 
∆Elect and were then ranked according to Etotal. Out of these 195 remaining molecules (180 
with 2 H-bonds, 7 with 3 H-bonds, 8 with 4 H-bonds), a set of 32 molecules for compound 
purchase was assembled.  
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Alpha Screen Assay: 
Prior to measuring single dose and dose-response values, all compounds were dissolved/diluted 
in DMSO to a concentration of 50 µM (with the exception of ZINC22642290 which was diluted 
to 25 µM). Both, single-dose and dose-response measurements determining the half maximal 
inhibitory concentration (IC50) for each compound were performed by Reaction Biology Corp. 
deploying the ALPHA Screen binding assay. In this assay donor beads coated with streptavidin 
were incubated with biotinylated histone H3 (residues 1-30) containing Kac (K14/18/23/27Ac-
GG). Fluorescence at 520-620 nm resulting from the close proximity of Kac with SMARCA4 
after excitation at wavelength of 680 nm was then measured in the EnVisionTM multilabel plate 
reader for solutions containing the ligand and without. IC50 measurements for PFI3 (control) 
and ZINC04181101 were tested in 10-dose mode with 3-fold serial dilution starting at 50 µM.  
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Results  
Structure selection and binding site evaluation: 
For SMARCA4 there are currently three available 3D-structures out of which two structures 
were obtained by means of X-ray crystallography(3UVD, 2GRC) and one by NMR 
spectroscopy(2H60). Evaluation of the RMSD for all heavy atoms between 3UVD and 2GRC 
is 0.27 Å while between 3UVD and 2H60 the RMSD is 1.85 Å. A different orientation of the 
aZ’-aZ loop in 2H60 is the conformational feature which contributes most to the higher RMSD 
between 3UVD and 2H60 while the binding site is highly similar in conformation 
(Supplementary 1). The decision for utilizing 3UVD for the virtual screening campaign was 
finally based upon this being a co-crystal structures with bound 1-methylpyrrolidin-2-one 
which served as the reference compound for the fragment stage (Figure 2b). Estimating the 
interaction energy in SEED for the crystal conformation of 1-methylpyrrolidin-2-one resulted 
in a total energy of -8.16 kcal/mol which was the cut-off value do discard any docked fragment 
with a higher SEED total energy. Compared to other bromodomains, SMARCA4 provides 
mainly hydrophobic residues in its binding site (Figure 2a, c). Other than Tyr1497 and Asn1540 
which are conserved among the majority of bromodomains only Gln1487 features side chain 
hydrogen bond donors within 14 Å of 1-methylpyrrolidin-2-one. However, analysis of the 
flexibility of the simulations previously run on SMARCA4 by Steiner et al. 2013 showed that 
the Gln1487 sidechain is freely moving and thus does not provide any stable or meta-stable 
conformation which could be selected to guide structure based design (Supplementary 2). All 
remaining residues in the Kac binding site are Val148, Phe1485, Ile1486, Leu1488, Pro1489, 
Leu1494, Val1505, Ala1532, Phe1539 and Ile1546 (Figure 2c). Hydrogen bond acceptors are 
contributed by the backbone carbonyl atoms of Val1484, Gln1487, and Val1505. The backbone 
conformation of 3UVD does not provide for any hydrogen bond donors which could be 
exploited.  
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Fragment generation and fragment docking: 
The ZINC library still constitutes the largest available chemical available for virtual screening 
campaigns. At the beginning of the in silico campaign (10 2014), version 12 of the ZINC 
database contained 22,724,825 molecules which were fragmented at every heavy atom – heavy 
atom bond into 204,754 unique fragments. As SEED is not able to rotate dihedral angles in 
molecules, at first only molecules featuring no rotatable bonds were selected for fragment 
docking.  However, as hydroxyl groups are both rotatable and provide a very potent H-bond 
donor-acceptor-pairs, molecules containing hydroxyl groups were kept. This yielded a fragment 
library of 41,623 fragments eligible for docking in SEED. Since the CHARMM General Force 
Field (CGenFF) currently represents the most versatile small molecule parameters, all 
fragments were parameterized for CGenFF via MATCH which resulted in a net loss of 7,548 
molecules which could not be parameterized due to the unavailability of parameters as well as 
substitute parameters, bond increment rules for calculation partial charges and inadequate 
fragments derived from parent ZINC molecules. After docking a total of 37,075 fragments into 
3UVD, 32,746 molecules passed the cut-off set by the reference value of -8.16 kcal/mol of 1-
methylpyrrolidin-2-one. Hydrogen bonds provide a significant interface for the interaction of 
small molecules with their respective protein target. As the strength of a hydrogen bond is 
defined by distance between the donor/acceptor heavy atoms and the angle between the donor 
pair and acceptor atom, more rigid distance and angle criteria of 2.5 - 3.0 Å and 180° (±30°) 
respectively were chosen. All SMARCA4-fragment-complexes were evaluated for at least a 
single H-bond, resulting in 1,057 fragments. 
Substructure Search: 
In accord with the ALTA procedure, a substructure search was performed via RDKit to identify 
potent molecules containing the promising fragments identified in the fragment stage.  To keep 
the moieties involving H-bonds intact and simultaneously allow for more combinatorial 
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possibilities, all polar hydrogens which provided the interface for a H-bond were kept while all 
other hydrogens were deleted. This yielded a total of 1,165,191molecules representing a 
chemical space reduction by a factor of 101 from the size of the original size of the ZINC set. 
Unsurprisingly, phenol was the most common fragment identified in 458,510 molecules. To 
further reduce the chemical space, chemically unfavorable moieties (Supplementary 3) were 
searched for by substructure search and molecules containing them were removed from the set. 
As solubility is a prevalent issue in all stages of drug development not only the “Hit phase”, a 
clogP < 5 was enforced while all other Lipinski rules were disregarded to not further restrict 
the chemical space. Finally, all molecules were checked for actual availability and vendor 
information on the ZINC database leaving a total of 921,779 parent molecules ready for 
docking, energy evaluation, and subsequent ordering. All molecules unavailable for purchase 
despite displaying promising in silico properties otherwise were set aside for later virtual 
screening campaigns.  
 
Docking, Scoring, and Selection: 
The prime advantage of the ALTA procedure and fragment-based design generally, lies in the 
extension of potent fragments into parent molecules of higher potency while keeping the 
fragment in its original conformation. A side effect is the reduction of chemical space by 
removing all molecules which do not contain the wanted fragments. To achieve this goal we 
incorporated the capabilities or rDock for tethered docking into the design process. Tethered 
docking allowed for the initially docked fragment to maintain its relative position from the 
fragment stage, while the rest of the molecule could move freely.  Subsequent to docking, all 
fragments were evaluated via the rDock score and molecules having a positive score indicating 
unfavorable poses were discarded while molecules passing the threshold were then evaluated 
for the amount of hydrogen bonds they formed with SMARCA4. The side chain carbonyl 
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oxygen and amide hydrogens of Asn1540 provide a H-bond donor/acceptor pair in a very short 
distance and interaction with both of them was preferred thus, all molecule containing only a 
single H-bond were not considered for the subsequent steps. As the residues considered for 
docking in the Kac binding site of SMARCA4 do not contain a single charged residue, all 
molecules with a non-zero net charge were removed. Deploying interaction energy calculations 
with continuum electrostatics in CHARMM for 112,950 molecules resulted in 759 molecules 
featuring a negative Etotal. This number was further reduced by requiring a negative ∆Elect for 
molecules with 2 H-bonds prior to minimization which lead to a final set of 180 molecules 
which were visually inspected. Only 7 (3 H-bonds) and 8(4 H-bonds) molecules had a negative 
Etotal after CHARMM minimization and energy evaluation. It is worthwhile to point out that 
many of these molecules had a positive ∆Elect due to the amount of non-carbon atoms, resulting 
in a significant amount of hydrogen bond donors/acceptors per molecule. Finally, a selection 
of 32 molecules were then tested (Table 1) in a single dose ALPHA screen. 
 
In vitro ALPHA screen and putative binding mode: 
A total of 32 molecules were purchased and then selected for single dose testing via ALPHA 
screen. At 50 µM, controls Bromosporine and PFI showed 43.6 % and 14.7 % relative signal 
(Table 2) while ZINC04181101 showed 14.4 %. Reduction of signal below 78 % was not 
detected for any other compounds tested. A dose response series measured for PFI3 resulted in 
an IC50 value of 271 nM while ZINC04181101 had an IC50 value of 20 µM. ZINC04181101 
represents a scaffold connecting two ring systems, a phenol and trans-glycoluril, by a N-
methleneaminoacetamide linker. Assessment of the absorption spectrum of this compound 
showed no indication of interference at the wavelengths the ALPHA screen is performed 
(Supplementary 5). ZINC04181101 is one of 4 molecules which featured 4 hydrogen bonds 
with SMARCA4 after docking with rDock. Out of which one was removed after energy 
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minimization via CHARMM. Despite this compound having a formal charge of 0, ∆Elect was 
12.4 due to the number of hydrogen bond donors and acceptors (Table 1). The minimized 
position shows that ZINC04181101 forms three hydrogen bonds (Figure 5). Two of these are 
contributed through the trans-glycoluril moiety with the sidechain Asn1540 while the trans-
glycoluril group forms another hydrogen bond with the carbonyl backbone oxygen of Gln1487. 
The third hydrogen bond between ZINC04181101 is formed via the N-
methleneaminoacetamide group with Asn1540. Despite an additional hydrogen bond 
donor/acceptor pair provided by the phenol group, no other H-bond is formed.  
The ligand efficiency (LE) calculated according to (1) of ZINC04181101 is 0.28 while 
the ligand lipophilic efficiency (LLE) calculated via (2) is 1.82. 
 = 	
.
	
	
                                                  (1) 
Where N is the number of heavy atoms and pIC50 is the negative decadic logarithm in M.  
                                                              = 
 −                                                 (2) 
pIC50 as above while the cLogP was estimated as 2.87 according to the method of Viswanadhan 
et al. 1989 implemented in the Marvinsketch (version 14.11.24.0, Chemaxon 
http://www.chemaxon.com) node for Knime53,54. The authors like to point out that the calculated 
LogP according to Wildman & Crippen 1999 as implemented in RDKit is -1.16 and the reported 
xLogP on the ZINC webserver for entry ZINC04181101 is 0.1155. Therefor the LLE can change 
significantly based on the method of LogP calculation.  
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Conclusions 
We have presented the in silico identification and in vitro validation of a small molecule 
displaying low µM activity for the SMARCA4 bromodomain. The in silico screening has 
involved fragment docking by the program SEED followed by tethered docking (using rDock) 
of the subset of molecules that contained one or more of the top fragments. The reduction of a 
multi-million library of compounds to 32 molecules for in vitro assessment was achieved by 
applying as threshold the calculated binding energy of a structurally resolved fragment as well 
as hydrogen bond enumeration, van der Waals interaction energy, and the electrostatic 
contribution to the free energy of binding using the continuum dielectric approximation. The 
trans-glycoluril moiety provides two out of three hydrogen bonds with Gln1487 and Asn1540, 
and might serve as an anchor point for future derivatization. It would be worthwhile to 
investigate if substituting the trans-glycoluril into a cis-glycoluril results similar activity. As the 
phenol group does not seem to provide significant interaction, it is there were derivatives should 
be first considered. Removal of the phenol group would increase the ligand efficiency due 
reduction of the molecules by 6 aromatic carbons. Despite the projected low druggability of 
SMARCA4, PFI3, the 2-thiazolidinone derivatives by Zhao et al. 2015 and the here presented 
ZINC04181101 represent three distinct scaffolds which represent a diverse series of scaffolds 
worthwhile for optimization in order to provide drug candidates to tackle SMARCA4 and 
SWI/SNF mediated diseases56–58.  
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Figure 5 
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Table 1 
  
ZINC39404578 2 -35.5 -12.8 17.0 4.2 -9.6 -11.3 -1.8 -31.3
ZINC66699837 2 -32.0 -14.4 22.0 7.6 -10.8 -11.5 -0.6 -24.4
ZINC12863354 2 -27.2 -3.5 7.6 4.1 -7.0 -7.6 -0.6 -23.2
ZINC42735712 2 -25.7 -5.3 8.8 3.5 -7.8 -8.4 -0.7 -22.2
ZINC84678055 2 -25.8 -3.6 7.9 4.2 -5.7 -6.0 -0.3 -21.5
ZINC71920814 2 -26.0 -9.2 14.2 5.0 -9.2 -9.6 -0.4 -21.0
ZINC12858178 2 -23.6 -4.9 7.7 2.8 -5.7 -6.5 -0.8 -20.8
ZINC22642290 2 -25.0 -10.4 14.6 4.2 -8.4 -8.8 -0.4 -20.7
ZINC04940185 2 -23.5 -5.7 9.4 3.7 -6.1 -6.3 -0.3 -19.8
ZINC12901687 2 -26.2 -8.7 15.5 6.8 -6.4 -6.6 -0.2 -19.4
ZINC05417915 2 -25.4 -8.4 14.5 6.1 -7.5 -8.8 -1.3 -19.3
ZINC14121148 2 -23.6 -6.3 10.8 4.5 -5.9 -6.7 -0.8 -19.1
ZINC95356471 2 -19.9 -4.6 5.5 0.8 -7.1 -7.2 -0.1 -19.0
ZINC95348176 2 -21.3 -3.3 5.7 2.4 -8.2 -8.3 -0.1 -18.9
ZINC32855766 2 -22.6 -2.7 6.8 4.1 -5.4 -5.5 -0.1 -18.5
ZINC00127673 2 -20.8 -2.7 5.1 2.4 -5.2 -5.8 -0.5 -18.4
ZINC00076820 2 -21.1 -4.6 7.5 2.9 -5.1 -6.2 -1.1 -18.2
ZINC04206597 2 -20.5 -2.8 5.2 2.4 -5.3 -5.8 -0.5 -18.1
ZINC12804112 2 -19.8 -3.0 5.2 2.2 -5.7 -5.8 0.0 -17.6
ZINC41121701 2 -19.9 -7.0 9.5 2.5 -5.5 -5.9 -0.4 -17.5
ZINC33207842 2 -21.1 -10.3 14.1 3.8 -8.1 -8.2 -0.1 -17.3
ZINC91264242 2 -22.1 -6.4 11.4 5.0 -10.4 -11.2 -0.8 -17.2
ZINC16946449 2 -18.7 -6.8 8.4 1.6 -5.9 -8.3 -2.4 -17.1
ZINC04206529 2 -19.3 -4.0 6.4 2.4 -5.9 -6.3 -0.4 -16.9
ZINC00076824 2 -18.9 -4.2 6.2 2.0 -6.9 -7.3 -0.4 -16.9
ZINC04940173 2 -19.0 -3.8 6.0 2.2 -4.7 -6.1 -1.4 -16.9
ZINC14505663 2 -16.1 -8.2 7.5 -0.7 -7.3 -10.7 -3.4 -16.8
ZINC02732051 2 -19.2 -5.1 7.5 2.5 -5.7 -6.1 -0.4 -16.8
ZINC45236747 2 -18.2 -4.8 6.3 1.5 -4.1 -5.6 -1.5 -16.7
ZINC36756146 2 -17.7 -4.6 5.5 0.9 -5.3 -6.5 -1.3 -16.7
ZINC35207533 2 -17.3 -3.4 4.4 1.0 -5.1 -6.4 -1.3 -16.3
ZINC12783212 2 -21.1 -8.3 13.2 4.9 -6.3 -6.4 -0.1 -16.1
ZINC59919622 2 -17.7 -5.3 6.9 1.7 -6.2 -7.1 -0.8 -16.0
ZINC31439120 2 -20.7 -8.4 13.0 4.6 -6.5 -6.6 -0.1 -16.0
ZINC94618071 2 -17.4 -9.6 13.1 3.5 -7.5 -8.0 -0.5 -13.9
ZINC01089842 2 -13.8 -4.9 5.4 0.5 -6.7 -7.3 -0.6 -13.3
ZINC01679277 2 -15.6 -4.4 6.8 2.5 -6.2 -6.4 -0.2 -13.2
ZINC71920814 3 -25.6 -10.8 15.5 4.7 -9.1 -9.2 -0.2 -20.9
ZINC40773700 3 -21.0 -12.1 16.2 4.1 -8.3 -9.7 -1.3 -17.0
ZINC31439120 3 -20.7 -8.4 12.9 4.5 -6.5 -6.6 -0.1 -16.1
ZINC37864247 3 -25.1 -5.5 17.5 12.1 -41.3 -9.8 31.5 -13.0
ZINC33269125 4 -29.8 -12.1 19.9 7.7 -35.9 -10.1 25.8 -22.0
ZINC12769485 4 -27.9 -12.9 19.3 6.4 -32.8 -11.0 21.8 -21.5
ZINC95449202 4 -22.6 -4.6 13.7 9.1 -9.0 -3.4 5.6 -13.6
ZINC04181101 4 -23.2 0.3 10.6 11.0 -17.5 -5.1 12.4 -12.3
ΔEvdw ΔEcoulomb ΔEsolv ΔGelec ΔEsolv,l ig Einter,solv ΔElect EtotalZINC ID H-bonds
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Figure and Table legends: 
Figure 1: Selection of small molecules for which inhibitory and dissociation constants have 
been reported for SMARCA4. a,b) Four derivatives of a single compound developed for BET 
bromodomains. c) 1,3-dimethyl benzimidazole compound developed for BRPF1 pKD value 
obtained for SMARCA4 through via bromoscan. d) Only PFI3 is reported as a dedicated 
chemical probe for SMARCA4 while other reported inhibitors were identified as part of 
investigations into selectivity for the original target. All 2D depictions of small molecules were 
generated via ChemDraw Pro 12 (CambridgeSoft, Cambridge, MA, United States). 
Figure 2: Overview of SMARCA4 sequence and structural information. a) Annotated sequence 
of the SMARCA4 bromodomain. Fragments were docked to the residues underlined in black. 
b) Three dimensional structure of SMARCA and 1-methylpyrrolidin-2-one forming a single 
hydrogen bond with Asn1540 (PDB-ID: 3UVD). The motifs of the conserved bromodomain 
fold are colored according to subplot a). Structural waters and 1-methylpyrrolidin-2-one are 
shown in sticks. c) Kac binding interface of SMARCA4. Residues involved in fragment and 
molecule docking are shown in sticks and annotated. Residues highlighted in had a 
conformation providing hydrogen bond acceptors while residues highlighted in purple could 
contribute both H-bond acceptor and donor. All other residues only engaged in hydrophobic 
interactions with a potential ligand. The majority of residues in the binding site are of 
hydrophobic nature. Figures b) and c) rendered in Pymol Version 1.7.4 Schrödinger, LLC. 
Figure 3: Overview of the virtual screening with annotated number of molecules and fragments 
respectively. Each step in the virtual screening for the molecule stage generally features the 
desired reduction of chemical space by a factor of 10. The fragment stage is shown in dashed 
lines while the full molecule stage is shown in solid lines. The only compound showing activity 
20 µM is depicted in 2D.  
Figure 4: IC50 curves for the control PFI3 and ZINC04181101 measured via ALPHA screen.  
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Figure 5: Docked pose of ZINC04181101. The hydrogen annotated in yellow dashed lines 
show two hydrogen bonds formed with Asn1540 while a third one is formed with the backbone 
of Gln1487. The trans-glycoluril motif contributes a total of 2 hydrogen bonds both as acceptor 
and donor. In this pose the phenol group does not feature any distinct interaction.  No hydrogen 
bonds with water were detected. Waters, side chain atoms, and backbone atoms for Gln1487 
depicted as sticks. Figure generated in Pymol59.   
 
Table 1: Table of the 32 tested compounds and their respective in silico filter criteria after 
tethered docking. Before CHARMM energy evaluation the number of hydrogen bonds was the 
prime filtering criterion (column 2). Following CHARMM energy evaluation all molecules 
with a negative Etotal (Evdw + ∆Gelec) were discarded (column 10). ∆Gelec is calculated as the sum 
of ∆ECoulomb and ∆Esolv. ∆Elect was devised as a measure to assess favorable electrostatic 
interactions of the ligand inside the receptor compared to its solvated state and is calculated as 
the difference between Einter,solv and ∆Esolv,lig. Molecules featuring 3 or 4 hydrogen bonds have 
a comparatively high ∆Elect as their scaffolds provided more hydrogen bond donors/acceptors.  
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Supplementary Material: 
 
Supplementary 1: Alignment of the available crystal structures. a)  3UVD and 3GRC display 
very  little difference as the RMSD is 0.27 Å while the RMSD between 3UVD and 2HR6 
(NMR) is 1.85 Å. The biggest difference between the two structures is a different orientation 
of the aZ’-aZ loop (black dashed arrow). b) Close-up of the aligned binding sites of the 
respective SMARCA4 structures reveals that there are little differences in the residue 
orientations between the structures.  
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Supplementary 2: Flexibility of GLN1487. a) Surface view for all primary amine nitrogen 
atoms from the simulation indicating high flexibility and overall movement of the sidechain in 
the simulation performed by Steiner et al.52 b) Progress index (black line) and annotated 
distances between Gln1487 sidechain amide nitrogen. The progress index shows a single basin 
indicating no stable or metastable conformations of Gln1487. The progress index was generated 
in CAMPARI by involving all side chain heavy atoms of GLN1487. Prior to clustering via the 
tree-based cluster algorithm implemented in CAMPARI the backbone of all SMARCA4 
residues were aligned. 
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[Br,Cl,I][CX;CH,CH2], reactive alkyl halides 
[S,C](=[O,S])[F,Br,Cl,I] acid halides 
O=CN=[N+]=[N-] carbazides 
COS(=O)=[C,c] sulphate esters 
C(=O)OC(=O) acid anhydrides 
OO peroxides 
C(=O)Oc1c(F)c(F)c(F)c(F)c1(F) pentafluorophenyl esters 
C(=O)Oc1ccc(C(=O)=O)cc1 paranitrophenyl esters 
C(=O)Onnn esters of HOBT 
N=C=[S,O] Isocyanates Isothiocyanates 
OS(=O)(=O)C(F)(F)F Triflates 
P(=S)(S)S lawesson's reagent and derivatives 
cN=[N+]=[N-] aromatic azides 
C(=O)C[N+,n+] beta carbonyl quaternary nitrogen 
C=P posphoranes 
[Cl]C([C&R0])=N chloramidines 
[N&D2](=O) nitroso 
[P,S][Cl,Br,F,I] P/S Halides 
N=C=N Carbodiimide 
C(=O)N(C(=O))OC(=O) triacyloximes 
N#CC[OH] cyanohydrins 
P(OCC)(OCC)(=O)C#N cyanophophonates 
C(=O)O[C,H1].C(=O)O[C,H1].C(=O)O[C,H1] > 2 ester groups 
C(=O)[Cl,Br,I,F] acid halide  
[CH1](=O) aldehyde  
N=[N+]=[N-] Azido group  
N#N Azo group  
[C,c](=O)[CX4,CR0X3,O][C,c](=O) beta-keto/anhydride  
[C+,c+,C-,c-] Carbo cation/ anion  
[O+,o+,S+,s+] charged oxygen or sulfur atoms 
C1(=[O,N])C=CC(=[O,N])C=C1 chinone  
C1(=[O,N])C(=[O,N])C=CC=C1 chinone  
C=[C!r]C#N conjugated nitrile group  
[N!R]=[N!R] diazo group  
[C,c](=O)[C,c](=O) diketo group  
SS disulphide 
C(=O)Onnn ester of HOBT  
[Hg,Fe,As,Sb,Zn,Se,se,Te,B,Si] heavy metal  
[NX3R0,NX4R0,OR0,SX2R0][CX4][NX3R0,NX4R0,OR0,SX2R0] het-C-het not in ring  
N[NH2] hydrazine 
C=[N!R] imine 
N=[CR0][N,n,O,S] imine  
N=C=O isocyanate  
C=C=O ketene 
S1C=CSC1=S methylidene-1,3-dithiole 
C=!@CC=[O,S] Michael acceptor 
[$([CH]),$(CC)]#CC(=O)[C,c] Michael acceptor 
[$([CH]),$(CC)]#CS(=O)(=O)[C,c] Michael acceptor 
C=C(C=O)C=O Michael acceptor 
[$([CH]),$(CC)]#CC(=O)O[C,c] Michael acceptor 
[NX2,nX3][OX1] N oxide 
[NX3,NX4][F,Cl,Br,I] N-halo 
n[OH] N-hydroxyl pyridine 
[#7]-N=O N-nitroso  
[C,c]=N[OH] oxime 
[C,c]=NOC=O oxime 
OO peroxide 
c1ccccc1OC(=O)[#6] phenol ester 
c1ccccc1OC(=O)O phenyl carbonate 
[CR0]=[CR0][CR0]=[CR0] polyene 
[s,S,c,C,n,N,o,O]~[nX3+,NX3+](~[s,S,c,C,n,N])~[s,S,c,C,n,N] quaternary nitrogen 
[s,S,c,C,n,N,o,O]~[n+,N+](~[s,S,c,C,n,N,o,O])(~[s,S,c,C,n,N,o,O])~[s,S,c,C,n,N,o,O] quaternary 
nitrogen 
[*]=[N+]=[*] quaternary nitrogen 
[Si][F,Cl,Br,I] silicon halogen 
[SX3](=O)[O-,OH] sulfinic acid 
[SX2]O sulfur oxygen single bond 
SC=O thioester 
*1[O,S,N]*1 Three-membered heterocycle  
OS(=O)(=O)C(F)(F)F triflate  
[SiR0,CR0](c1ccccc1)(c2ccccc2)(c3ccccc3) triphenyl methyl-silyl 
 
Supplementary 3:  SMARTS patterns for the reduction of chemical space. 
 
 
 117 
 
 
Supplementary 4: Single dose ALPHA screen measurements. The competition-based assay 
results in a reduced when K14/18/23/27Ac-GG is displaced by the respective inhibitor. The 
values represent percentages in change of fluorescence at 520-620 nm in comparison to a 
solution with no inhibitor present.  
 
 
 
ZINC_ID measurement 1 measurement 2 average
ZINC95356471 104.70 104.01 104.4
ZINC04206597 104.01 101.91 103.0
ZINC41121701 104.25 100.45 102.4
ZINC22642290 91.97 92.32 92.1
ZINC95449202 110.60 105.66 108.1
ZINC01089842 102.48 103.56 103.0
ZINC02732051 98.70 102.05 100.4
ZINC05417915 106.42 104.11 105.3
ZINC04181101 14.44 14.38 14.4
ZINC33269125 106.43 103.64 105.0
ZINC04940173 96.69 99.30 98.0
ZINC04940185 94.11 94.16 94.1
ZINC00127673 103.70 100.90 102.3
ZINC00076820 97.68 100.17 98.9
ZINC00076824 99.37 98.11 98.7
ZINC31439120 101.83 99.76 100.8
ZINC04206529 99.10 104.50 101.8
ZINC36756146 97.41 105.80 101.6
ZINC12783212 104.46 102.54 103.5
ZINC12769485 89.68 90.51 90.1
ZINC12901687 87.93 84.81 86.4
ZINC33207842 95.71 95.06 95.4
ZINC12858178 99.64 102.74 101.2
bromosporine 46.57 46.12 46.3
ZINC42735712 101.83 101.77 101.8
ZINC12863354 79.05 78.48 78.8
ZINC84678055 96.01 95.42 95.7
ZINC32855766 93.78 91.62 92.7
ZINC14121148 88.86 90.34 89.6
ZINC12804112 97.48 97.83 97.7
ZINC66699837 104.93 102.60 103.8
ZINC05417915 110.52 114.46 112.5
ZINC71920814 98.60 98.11 98.4
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Supplementary 5: Raw data of ALPHA Screen measurements for the IC50 curves of PFI3 and 
ZINC04181101 (S9:internal naming). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Raw Data Conc (M) S9 PFI3 Conc (M)
1.00E-04 23995 16277 4.00E-05
3.33E-05 78394 17787 1.33E-05
1.11E-05 154392 24740 4.44E-06
3.70E-06 177654 39825 1.48E-06
1.23E-06 212296 82876 4.94E-07
4.12E-07 214575 138648 1.65E-07
1.37E-07 210676 188650 5.49E-08
4.57E-08 211693 220931 1.83E-08
1.52E-08 222241 226555 6.10E-09
5.08E-09 214781 221497 2.03E-09
DMSO 224381 230808 DMSO
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Supplementary 6: Absorption spectrum for ZINC04181101 diluted to 50 µM in DMSO. The 
measurement was performed on a NanodropTM in a wavelength region between 300 and 700 
nm against a blank solution of DMSO. 
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Chapter 5 
 
Molecular dynamics analysis of iriomoteolide 3a and 
reidispongiolide A binding to monomeric actin 
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5.1 Introduction 
 
5.1.1 The cytoskeleton 
The cytoskeleton is constituted of three prime cytoskeletal structures: microtubules (MT), intermediary 
filaments (IF) and actin/micro filaments (MF) (Figure 1)1–3. In the cell these structures are present as 
polymers of varying lengths, constituted of highly ordered and repetitive units of various structural 
proteins, most prominently actin, tubulin, and the sequence homology class (SHC) members of IF.  
 
Microtubules are cylindrical, hollow polymers with an outer diameter of 24 nm and an inner diameter 
of 12 nm composed of different tubulin species (α, β, γ, δ, ε, ζ) featuring several subtypes each (Figure 
2). Structure and composition are generally determined by cell type and functional role of the 
microtubule. The most common tubulin species are α- and β- tubulin which respectively have a 
molecular weight of ~ 50 kDa. Via their GTPase activity, α- and β- tubulin assemble initially by forming 
αβ-hetero dimers which in-turn assemble, head to tail, into protofilaments. An average of 13 
protofilaments assemble into short-lived sheets which then laterally fold into the final cylindrical and 
polar structure with a fast-growing plus-end (+) and a slow growing minus-end (-)4. In eukaryotes the 
minus-end is generally attached at the centrosomes, where γ-tubulin plays a key role initializing 
protofilament formation, while the (+) end grows towards the designated cell compartment. 
Microtubules have been shown to stochastically undergo phases of shrinking and growing in vitro and 
in vivo5–7. This dynamic instability is central to the function of the microtubule as this, for example, is 
the mechanism by which chromosomes are separated upon mitosis8. The dynamics of rescue (growth 
after a pause event) and catastrophe (shrinkage after a pause event) are influenced by a multitude of 
proteins as well as organic- and inorganic molecules9. The polymerization of αβ-hetero dimers into 
protofilaments requires the energy set free upon hydrolysis of guanosin-5'-triphosphate (GTP) bound to 
β-tubulin into remaining guannosin-5'-diphosphate (GDP) and dissociating inorganic phosphate10. The 
specific arrangement of an inter-dimer interface is crucial for the GTPase activity which leads to 
hydrolysis and subsequent polymerization. Polymerization of the tubule is halted by GTP caps which 
prevent further polymerization and depolymerization11,12. Residual GTPs bound to β- tubulins are also 
distributed within the fiber which is hypothesized to be integral in the dynamic equilibrium between 
polymerization and depolymerization of the microtubule. The dynamic changes in length of  
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Figure 1: Schematic of epithelial cells depicting the three main constituents of the cytoskeleton. Actin 
filaments/micro filaments are depicted in red while microtubules and intermediate filaments are depicted in green 
and blue respectively. The nucleus is highlighted as a brown ellipsoid while the spindle apparatus is shown in 
yellow. 
 
 
microtubules is central in the relocation of cell compartments and multitudes of proteins13. Microtubules 
feature one of the largest amount of protein-protein interactions. Not only are proteins influencing 
polymerization and depolymerization rates of microtubules, they also associate and re-locate alongside 
the stable tubule regions.  
Compared to microtubules, intermediate filaments (IF) are made up of a vast number of different 
proteins and are usually located in the cytoplasm as well as the nucleus14,15.  Their prime function in 
adult organisms is the shaping of cells and their interfaces the adjacent environment. IF are categorized 
into 5 sequence homology classes (SHC)16. Acidic and basic keratins are type 1 and 2. Type 3 
encompasses vimentin, desmin, and GFAP while neurofilament proteins are type 4 and nuclear lamins 
make up type 5 IF17. Sequence and structural analysis has revealed that there are several proteins (e.g 
nestin and filesin) which are highly similar to the IF superfamily but can’t be directly categorized into 
the above five classes. Despite these five different types and several subtypes, all IFs and related proteins 
share a similar 45 nm central α-helical ‘rod’-domain encompassed by N-terminal (head) and C-terminal 
(tail) domains (Figure 3)16. Notably, the assembly into the final cytoskeletal structure happens via lateral 
association of the subunits within seconds. Additionally, the assembly doesn’t require co-factors 
compared to microtubules or microfilaments and the final IF is highly robust against a multitude of 
environmental factors like pH, temperature, and mechanical stress.  
actin filaments microtubules intermediate filaments
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Figure 2: Schematic of microtubule assembly. a) Intermediaries of the microtubules including the two subunits 
α,β tubulin and an example protofilament of which several are assembled into the final  microtubule. b) Pymol-
generated depiction of a X-ray crystal structure of the α,β tubulin dimer. GTP is shown in magenta sticks. (PDB-
ID: 4FFB, protein STU2 and Mg2+ are omitted)18. All Pymol-related images were generated via version 1.7.0.019. 
 
At the beginning of the assembly, two polypeptide chains align in parallel and in register to form the 
initial coiled coil complex which further matures into the IF structure at low pH with the addition of 
other proteins (Figure 3)20. The alignment happens without the assistance of auxiliary proteins and is 
therefore considered intrinsic to the structure. IF notably are not made up of globular subunits but long 
polypeptides aligned in an anti-parallel manner resulting in a non-polar super structure. The most 
distinguishing feature of IF, is the ability of high extensibility and stress resistance not observed in MT 
or MF. This property is related to the coiled coil structure of the filaments. Diseases related to mutations 
in IF protein genes like keratin present themselves in severe structural weaknesses of cells, tissues, and 
organs at very distinct stages of development. Muscular dystrophies, cardiovascular as well as 
Hutchinson-Gilford progeria syndrome and atypical Werner syndrome occur in post-infant stages while 
mutations in GFAP genes lead to severe disruption of normal development of the brain and skull 
(Alexander disease)21. Epidermolytic diseases become less severe with age, indicating a change of 
molecules interacting with IF leading to hypotheses that such diseases result in the hindered interplay 
of proteins associated to IF.  
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Figure 3: Simplified overview intermediate filament assembly. a) Example schematic of stages of IF assembly. 
From top to bottom a simple monomer, a coiled coil dimer, and an associated tetramer stemming from one dimer 
associated via the C-terminal tail to the coil of an adjacent dimer. b) X-ray crystal structure of a fragment of a 
vimentin coil 2 homo 4-mer (PDB-ID: 3KLT)22. Each individual chain in shown in a different color. All non-
peptidic content was removed before rendering the image with Pymol19. 
 
5.1.2 Actin 
The dynamic structure of actin filaments is vital for every biological mechanism that requires cellular 
scaffolding. As one of the most abundant proteins in eukaryotic cells (ranging from 5% - 10% in any 
cell to ~20% in muscle cells), actin filaments provide and maintain the cellular three-dimensional 
structure, provide cell motility, are vital in cytokinesis, and muscle contraction23. Actin is most 
abundantly located in the near cell membrane region called the cell cortex. Compared to microtubules 
and intermediate filaments, the length of actin filaments are the shortest with a persistence length of 3-
6 nm. It's dynamics of polymerization/depolymerization as well as the ability of crosslinking enable 
actin towards a broad diversity of mechanical behaviors. Actin is highly conserved among species with 
an average of 80% identity between humans and yeast and has many related proteins in prokaryotes24. 
Myriads of proteins are known to bind to actin of which myosin is probably the most prominent one, 
determining muscle contraction and relaxation25. Proteins binding to actin are not only subject to its 
relocating effects but also regulate polymerization and depolymerization as well as crosslinking25.  
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Figure 4: Systematic close up of an actin filament towards the monomeric actin subunit. a) Schematic of an actin 
filament (July 2001 Molecule of the Month by David Goodsell, RSCB Protein Data Bank, www.rcsb.org). b) 
Hypothetical model of three actin monomers with ADP as the bound nucleotide and dummy ion as a substitute for 
Mg2+/Ca2+ 26. Each monomer is represented as cartoon in a distinctly colored cyan, the molecular surface is kept 
transparent. Image rendered in Pymol. c) Pymol-visualized monomeric G-actin with bound ATP and Ca2+ (PDB-
ID: 2HF4). The subunits 1-4 are colored in distinct shades of cyan while the nucleotide is shown in magenta sticks 
and the Ca2+ ion is represented by an orange sphere19.  
 
Additionally to proteins, many small organic/inorganic molecules have been identified to bind to actin 
with ATP being the co-factor which enables polymerization of the globular G-Actin into F-Actin while 
other known non-protein molecules have an adverse effect on innate actin dynamics27. 
 
5.1.3 Monomeric globular actin and fibrous actin 
 Vertebrates encode genes for three main globular actin (G-actin) isoforms α-, β-, and γ-actin which are 
categorized by their unique isoelectric points. These isoforms are further differentiated into αskeletal-actin, 
αcardiac-actin, αsmooth-actin and γskeletal-actin which are primarily expressed in skeletal, cardiac, and smooth 
muscle tissue. γcyto-actin and βcyto-actin and expressed equally in all tissues28. High conservation of all 
six isoforms is present between mammals in birds where 93% sequence identity represents the low 
margin. Sequence differences are the highest towards the N-terminal region between different isoforms 
and their homologues29. The G-actin monomer has a molecular weight of 43 kDa comprised of 375 
residues. Flattened in one dimension, actin is made up of two major domains, a large inner domain and 
a small outer domain. These domains are further annotated into four subdomains (domains 1, 2, 3, 4) 
with the nucleotide binding cleft (NBC) located at the center between subdomains  
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Figure 5: Overview of actin polymerization/depolymerization dynamics. a) Mixture of ADP-actin and ADP-Pi-
actin. Without a specific environment monomeric actin will not associate beyond the stage of loose oligomers. b) 
The formation of stable nuclei is induced at high salt concentrations. Loose oligomers from which do not serve as 
stable seeds are associate regardless. c) Stable nuclei are polymerized into an actin filament. Polymerization and 
depolymerization takes place at both barbed end and pointed end. Nucleotide exchange from ADP-actin to ATP-
actin is what enables tread milling of the filament. All steps are influenced by a multitude of environmental factors 
such as pH, salt concentration, proteins, and organic/inorganic molecules.  
 
1,2 and 3,4 (Figure 4c)30. Together with the respective nucleotides adenosine-tri-phosphate 
(ATP)/adenosine-di-phosphate (ADP), a divalent cation Ca2+ or Mg2+ is also present in the cleft. Domain 
1 and domain 3 are structurally related and probably evolved from gene duplication31. Domain 2 and 
domain 4 are considered as insertions between domain 1 and domain 3. Considering the direction of 
polymerization of monomers, G-actin is additionally separated into the (-)/pointed end (domain 2,4) and 
(+)/barbed (domain 1,3)31. Structural data has led to the hypothesis that G-actin can be present in two 
conformational states which is dependent on the bound nucleotide. Particularly the preference of actin 
binding proteins (ABPs) like cofilin and profiling towards ADP-G-actin and ATP-G-actin compared to 
fibrous actin (F-actin) enabled early theories of nucleotide-dependence of G-actin conformations32.  
Direct structural insights into the nature of F-actin have remained elusive in recent years33. Crystals for 
X-ray crystallography are hard to obtain as the natural polymerization/depolymerization generate 
filaments of varying lengths. Data obtained by electron-microscopy shows F-actin to be consisting of  
 
  
a b
c
ADP-actin ADP-Pi-actin ATP-actin
(+)(-)
nucleotide exchange
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Figure 6: Schematic of the relationship of monomer concentration and formation of fibrous actin under 
conditions which enable polymerization. After the critical concentration (CC, dashed line) is reached additionally 
supplied actin monomers (red line) do not significantly increase the effective monomer concentration since all 
monomers are integrated into the filament upon polymerization which results in filament growth linearly correlated 
with supplied monomers (green line)34.  
 
two chains being intertwined in a right-handed “long-pitch” helix in which the inner domain is closer to 
the axis of the helix (Figure 4a)35. Today there are two models of the atomic nature of actin monomers 
in F-actin. The model proposed by Oda et al. in 2009 was obtained by optimizing the crystal structures 
of G-actin monomers into the helix of F-actin and then comparing it to X-ray fiber diffraction patterns. 
The model was improved by application of simulated annealing and other in silico techniques in order 
to improve the fit to the diffraction pattern. According to this model the transition from G-actin to F-
actin involves a 20° rotation of the outer domain in relation to the inner domain at a right angle to the 
helix. This rotation reduces the twist between the inner and outer domain and flattens out the molecule. 
Additionally, the D-loop of subdomain 2 is relocated inwards26. The Holmes et al. 1990 model of F-
actin was obtained in a similar fashion to the Oda model from an X-ray diffraction pattern into which 
monomeric actin coordinates were fit36,37. The prime difference to the Oda model is that the Holmes 
model does not provide for structural alterations of the actin monomer as the monomers are just stacked 
within the actin fiber38.  
monomer concentration
filament
stable nuclei
CC
monomer
m
a
ss
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Figure 7: Simplified representations of actin binding proteins disrupting the fibril dynamics. a) Mechanism of 
monomer sequestration. Profilin is able to bind to G-actins to prevent association at the barbed end thus reducing 
the effective critical concentration and subsequently polymerization39. b) The FH2 domain of formins acts as a 
nucleation enhancing molecule by stabilizing loosely associated oligomers into steady nuclei40. c) Capping of actin 
filaments is mediated by molecules attaching at both ends and circumvent the addition of novel monomers. 
Capping is a function shared by many F-actin severing molecules like Gelsolin41. d) Severing of F-actin by 
Gelsolin occurs with near 100 % efficiency at any point of the filament after which Gelsolin caps the pointed end. 
 
5.1.4 Actin polymerization and depolymerization 
The polymerization of G-actin monomers into actin fibers is considered to happen in three stages. A 
nucleation, elongation, and a steady phase (Figure 5)34. Nucleation happens in regions of high-density 
ATP-G-actin when at least three monomeric subunits begin to form a stable nucleus.  It is important to 
note that the formation of nuclei happens when a critical concentration of ATP-G-actin monomers is 
present (Figure 6). However, not all nuclei remain stable long enough for subsequent elongation to occur 
nucleation which leads to elongation is therefore heavily regulated by nucleation factors promoting 
nucleation and enabling stable trimers. In solution the assembly of nuclei is characterized by a lag phase 
which sees the typical formation of unstable oligomers. Eventually an oligomer will form a stable seed 
of three to four subunits. These stable nuclei then polymerize fast into a continuously growing actin 
fiber. It is important to realize that the filament grows in both directions with different rates. The barbed 
end (+) sees the addition of new sub unites 10 times faster than the pointed end (-).  
The elongation process will then continue until the steady state phase which is characterized by a  
a b
c d
profilin
formin
gelsolincap-Z
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Figure 8: Schematic of experimentally determined binding sites of actin-stabilizing natural products phalloidin, 
dolastatin 11, and amphidinolide H. Phalloidin depicted in red spheres was identified to bind the interface between 
three different actin monomers (pink, green, purple cartoon)42. Dolastatin (yellow spheres) has been shown to bind 
the interface made up of domains 1 and 4 of two adjacent actin monomers43. Amphidinolide H (not depicted) binds 
covalently to the yeast actin residue Tyr198 (depicted in sticks) and its mammalian homologue Tyr200 (image 
taken from Allingham et al. 2006)27,44. 
 
continuous exchange of G-actin monomers at the end of the filaments without any detectable change in 
F-actin mass. Upon reaching the steady state phase the remaining G-actin monomers are represented by 
the so called critical concentration (CC). The critical concentration is representative for the ability of 
the remaining G-actin solution to polymerize. Under standard in vitro conditions the CC of G-actins is 
0.1 µM above which the solution of G-actin will polymerize while F-actin will depolymerize if the 
concentration is lower.  Experiments in which the polymerization/depolymerization was blocked at 
either (+) end or (-) end did show that the CC is different for both ends. While the aforementioned CC 
0.1µM is measured primarily for the (+) end the (-) end has a CC of 0.8 µM. This difference leads to the 
observation of fiber “treadmilling”45. In the steady state phase there is constant fluctuation of the CC at 
both ends which eventually leads to the (+) end being constantly elongated while the (-) de-polymerizes. 
Under these conditions the effective length of the actin filament does not change while the fiber 
apparently moves into the direction of polymerization. Since the assembly of G-actin into the filament 
is dependent on the incorporation of ADP or ATP into the monomer. With increasing incorporation of 
ADP-actin into the filament the CC of the (+) end becomes identical to the CC of the (-)  
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Figure 9: Overview for 2D depictions of natural product actin binders27. a) The two modes natural products 
engage in upon binding to actin is filament severing and over stabilization. With the exception of latrunculins, all 
known severing NPs bind to the barbed end while latrunculins are located in the nucleotide binding cleft. Most of 
the severing NPs share a common molecular layout with a large macrolide ring and a flexible tail. b) Natural 
products which artificially over stabilize the actin filament share a common macrolide ring but decorations not as 
large as the tail section of the severing NPs.  
 
end. Similar to the polymerization process in general, the CC is also highly dependent on the 
environment. Polymerization dynamics are strongly influenced by pH, Ca2+/Mg2+ concentration, ionic 
strength of the solution, as well as temperature. Depending on the concentration of Ca2+/Mg2+, the CC 
can be high despite a high concentration of G-actin monomers.  
 
5.1.5 Disruption of actin dynamics 
As the dynamics of actin polymerization/depolymerization can be influenced at each of the 
aforementioned steps, a multitude of proteins is translated to ensure controlled actin dynamics1.  
Nucleation factors containing WH2-domains such as spire, cordon-bleu, leiomodoin and VopF/VopL 
are considered to bind to unstable actin oligomers to form stable nuclei while proteins such as 
WASP/WAVE/Scar enable nucleation along existing filaments in order to achieve branching46. 
Additionally, formin proteins associate via their formin homology domain (FH1/FH2) at the barbed end 
of profilin-actin and enable continuous addition of new monomers to the filament40. The gelsolin family 
of actin binders including gelsolin, adseverin, villin capG, advillin, supervillin and flightless I  
 132 
 
 
Figure 10: Example crystal structures of F-actin severing natural products. a-e) Kabiramide C, aplyronine, 
swinholide, reidispongiolide A, bistramide A all bind at the barbed extending from the periphery into the cleft 
between subdomains 1 and 347–51. f) Superposition of all severing NPs. Due to a different overall structure in 
bistramide A compared to other severing NPs, it is the only one which extends further into the subdomain 1,3 cleft 
while the other NPs have the macrolide located on the periphery and the tail inserted into the barbed end.  
 
serves both as nucleation promoters combined with capping properties at the barbed end (Figure 7)41. 
In addition, gelsolin binding to F-actin induces distortions to the filament which results in severing after 
which it also caps the barbed end.  Contrary to enhancing nucleation, the cofilin family, consisting of 
ADF/cofilin, twinfilin, Abp1/Debrin, coactosin, and the glia maturation factor have been identified to 
enhance pointed end depolymerization, increased release of Pi from ADP-Pi-F-actin, and inhibit the 
binding of myosin, tropopmyosin and phalloidin52,53. The binding of proteins of the gelsolin family to 
F-actin is primarily controlled via pH and reduces the longitudinal interaction between subunits in the 
filament. Compared to gelsolin, profilin binding to ATP-G-actin greatly enhances nucleotide exchange 
at the barbed end, resulting in 1,000 fold increase of barbed end polymerization while profiling is 
prevented from association with the pointed end where polymerization effectively halts. Additional to 
proteins, large natural product (NP) molecules have been identified to associate in a variety of ways 
with actin and disrupt polymerization and depolymerization dynamics27,48. Several natural inhibitors of 
actin are derived from deep sea sponges, bacteria, and fungus which produce these molecules as toxins  
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Figure 11: Overview of reidispongiolide A structural information. a) 2D depiction of reidispongiolide A 
generated with ChemDraw Pro 12 (CambridgeSoft, Cambridge, MA, United States). b) Ligplot+ depiction of 
interactions between redA and actin. The majority of interactions are van der Waals type and weak electrostatics. 
Hydrogen bond geometries indicating strong hydrophilic interaction were not satisfied54. c) Crystal structure 
showing the coordinates of redA interacting with actin.  
 
for both disabling prey and fending off predators27,55 The disruptive effects of these natural products are 
at the focus of research into understanding the dynamics of actin as well as promising precursors to 
drugs dealing with diseases characterized by defective actin dynamics. Natural products targeting actin 
are generally classified according to their site of interaction with actin and the effect on dynamics. There 
are two primary sites of interaction with actin, one being the ATP binding cleft which till today is 
targeted exclusively by latrunculin the other is the barbed end and its periphery56–58. The effects of 
natural products binding to actin is characterized by the two mechanisms of filament stabilization and 
inhibition of filament assembly or destabilization of the filament. Latrunculin A is the most prominent 
NP which binds to the ATP binding cleft and subsequently reduces binding cleft and subsequently 
reduces the inter-domain flexibility of the monomer which leads to impaired polymerization59. The main 
molecular feature by which this is accomplished is the thiazolidinone head group which interacts with 
Tyr69, Asp157, Arg183, Thr186, Arg206 and Arg210 via a distinct hydrogen bonding pattern59. The 
macrocycle provides bulk hydrophobic interaction with the monomer which then speculated to result in 
reduced degrees of freedom of the twist angle59. The effect of latrunculin interaction with actin  
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Figure 12:  a) 2D structure of iriomoteolide 3a generated with ChemDraw Pro 12. b) Effects of different 
concentrations of iriomoteolide on actin polymerization. On concentrations below 1 µM iriomoteolide displays 
behavior indicative of polymerization enhancing proteins like nucleation promoters. On concentrations above 50 
µM iriomoteolide, inhibition of actin polymerization was detected. Figure taken from Figure 33b of the Master’s 
thesis of Andrea Unzue Lopez entitled Iriomoteolides as novel chemical tools for the study of actin dynamics, 
University of Zurich 2012. 
 
on the polymerization dynamics is limited to sequestration of the monomers56. Contrary to latrunculins, 
other natural products identified to this day bind at the barbed end and the periphery such as trisoxazoles, 
reidispongiolides/sphinxolides, aplyronine A, scytophycin, swinholide A misakinolide A, 
lobophorolide, bistramide A, kabiramide C, cytochalasin, phalloidin, jaspakinolide, chondramide, 
doliculide, dolastasin, amphidinolide H and hecochlorin. These molecules engage in the two mentioned 
modes of disruption of filament dynamics. Kabiramide (trisoxazole), swinholide A, misakinolide, 
reidispongiolide, sphinxolide B, mycalolide (trsoxazole), aplyroninie, bistramide and cytochalasine all 
destabilize the formed actin filament while phalloidin, jasplakinolide, chondramide, doliculide, 
dolastatin, aphidinolide H and hectochlorin stabilize the actin filament (Figure 9,10)27. Most of the 
stabilizing NPs share a common general makeup, as in that they feature a large macro cycle made up of 
and decorated with hydroxyl, carbonyl, ether, methyl groups and a tail section (bistramide A and 
cytochalasin D are the two exemptions. Structural data provided insight into how these NPs probably 
destabilize the filament by association of the macrocycle with the hydrophobic patch located at 
subdomain 3 and subsequent insertion of the tail section into the barbed end (subdomain 1, 3)48. 
Destabilization of the filaments is primarily achieved via sequestering monomers from forming nuclei 
as well as association to the filament or severing an existing F-actin strand. While sequestration of 
monomers is mainly done by all destabilizers, severing and capping properties are not equally 
distributed. Natural products which stabilize the filament are structurally less understood as X-ray 
crystallography has not been able to provide such structures (Figure 8). Enhanced polymerization in 
their presence makes crystallization of complexes nearly impossible which results in the majority of 
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information being derived from x-ray fiber diffraction data, electron microscopy and biochemical 
assays. A cyclic depsipeptide is the most common feature of stabilizers present in phallodin, 
jasplakinolide, chondramide doliculide, dolastatin but not in amphidinolide H and hectochlorin. The 
mode of interaction of stabilizers understood through two examples. Phalloidin bridges three monomers 
in F-actin which appears to be stabilizing two long-pitch strands via interaction with residues 198-201 
of filament subunit n, residues 73-75 of subunit n+1, and residue 179 of a 3rd diagonal subunit42. 
Similarly, dolastatin 11 also bridges two long-pitch strands but by providing the strand interface at 
subdomain 4 of one monomer with subdomain 1 of the diagonal subunit43.   
 
Iriomoteolide 3a has been previously identified as a cytotoxic natural product of marine origin and its 
total synthesis was achieved in 200960–63. It is a 15-membered macrolide with an allyl-epoxide which 
was isolated from Amphidinium sp. (HYA024) and characterized by 2D-NMR. The cytotoxicity was 
established for human B lymphocyte DG-75 (IC50 of 0.08 µg/ml) and Raji cells infected with Epstein-
Barr (IC50: 0.05 µg/mL). Previous studies on the effect of iriomoteolide 3a on actin polymerization 
show that on low concentrations iriomoteolide displays increased polymerization similar to molecules 
which promote nucleation and polymerization64. On high concentrations (50 µM, 100 µM, 200 µM) the 
results show that iriomoteolide exhibits a polymerization inhibiting property (Figure 12b).These results 
as well as the similar makeup of iriomoteolide and natural products like reidispongiolide A (Figure 11a, 
12a) being a macrolide and tail was what initiated the investigations of iriomoteolide 3a binding towards 
actin as presented in this thesis chapter. 
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5.2 Methods 
 
5.2.1 Energy minimization and simulation protocols 
Coordinates for monomeric G-actin bound to gelsolin, ATP, and calcium (CA) were downloaded from 
the protein databank (PDB-ID: 1EQY)41. Coordinates for reidispongiolide A bound to G-actin were 
downloaded from the protein data bank (PDB-ID: 2ASM)48. Gelsolin, waters, and co-solvent molecules 
were manually removed from 1EQY and 2ASM. Any missing atoms from 1EQY G-actin residues 
ranging from 5 to 375 were added via CHARMM65–67. Parameters for all amino acids were created with 
the pdb2gmx module of GROMACS (version 3.3.6) for the CHARMM 27 protein force field 
parameters68–70. Parameters for calcium and ATP where also taken from the CHARMM 27 force field. 
For both systems (actin, ATP, CA, and iriomoteolide/reidispongiolide A) threonine 6 was capped with 
an n-terminal acetyl cap while the C-terminal phenyl alanine 375 was charged negatively71. The 3-
dimensional structure of iriomoteolide 3a was generated via Pymol and a TRIPOS MOL2 file was then 
generated manually19,72. Reidispongiolide A coordinates were taken from PDB-ID 2ASM and then 
converted into TRIPOS MOL2 format by hand. CHARMM General Force Field (CGenFF v. 2b7) 
parameters for iriomoteolide 3a and reidispongiolide A were obtained via uploading the respective 
MOL2 files to paramchem.org73–76. To make CGenFF parameter stream files (.str) compatible with 
simulations run in GROMACS (.itp), bond, angle, dihedral, improper units were converted from 
kcal/mol to kJ/mol and Ångstrom to nanometers respectively.  All 1-4 interactions were enumerated and 
pre-calculated via unit conversion of the original CHARMM parameters77.  
The subsequent preparation work flow is identical for all simulations of redA (bound and unbound) as 
well as iriomoteolide 3a (10 copies unbound and 1 copy unbound). Deploying the GROMACS package 
editconf, a dodecahedric box around the protein was created with a periodic boundary 1.2 nm distanced 
from the most outlying atoms of G-actin. For the simulations containing 10 copies of iriomoteolide 
simultaneously, the box was then filled with 10 copies of iriomoteolide at random positions determined 
by the genbox module of GROMACS. For the single copy iriomoteolide 3a/redA simulations, irio3a and 
redA were placed at random positions of the box. The system was then filled with repetitive units of 
pre-equilibrated SPC water coordinates parameterized for the TIP3P water model78–80. To neutralize the 
system sodium and chlorine ions were added at a concentration of 150 mM via the genion module of 
GROMACS.  
Each system was then minimized for 10,000 steps via the steepest descent minimizer or prematurely 
stopped if the total energy of the system was lower than 10 kcal. A minimization step size of 0.01 
kcal/mol was selected. After energy minimization, the system was equilibrated in a simulation for 1 ns 
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with random velocities and at constant temperature, pressure and number of particles (NPT) in which 
restraints were applied to all heavy atoms of G-actin, iriomoteolide, reidispongiolide A, ATP and CA 
while the  and NaCl ions and water could be propagated unrestrained. All production runs were started 
with new initial, random velocities. 
All simulations (including equilibration) were performed with a velocity rescaling thermostat and a 
Parinello-Rahman barostat at 1 atmospheric pressure unit and a temperature of 310 K81–83. The time 
step of the simulation was set to 2 fs. Long range vdW and electrostatic interactions were calculated 
with simple cut-off scheme and a particle mesh Ewald (PME) cut-off scheme at 1.2 nm84,85. The LINCS 
algorithm implemented in GROMACS was applied to constrain all atoms in the system86. For the 10-
copy iriomoteolide simulations 10 separate simulations were run for 100 ns with different initial 
velocities but identical positions of the respective iriomoteolides within box.  
For the 25 and 5 single iriomoteolide simulations, the simulation times were 100 ns and 700 ns 
respectively. The positions of iriomoteolide in the 25 100 ns simulations are identical to the 5 700 ns 
simulations each started 5 times with random velocities. Out of 25 100 ns iriomoteolide simulations, 5 
simulations were prolonged to a total of 300 ns each.  
Five simulations of bound reidispongiolide A were run for 100 ns each while the 5 simulations of 
unbound redA were simulated for 600 ns. All simulations were started with random initial velocities. 
Each simulation was performed on 64 Xeon 5560 processors clocked at 2.8 GHz each via MPI for 
GROMACS 3.3.6 on 64 cores per simulation. A reference .mdp file which was the template for all 
production run simulations can be found in supplementary material. 
 
5.2.2 Distance evaluation and contact frequencies 
Prior to analyzing the trajectories, all waters and ions were removed so that only G-actin, ATP and 
iriomoteolide/reidispongiolide A were contained in within the system. Movement of atoms across the 
PBC was removed in three steps via the trjconv GROMACS module. First, single atomic movement 
over the PBC was removed so that if a single atom would cross the PBC the entire molecule would be 
propagated (-pbc mol). In a second trjconv step G-Actin, ATP, and iriomoteolide/reidispongiolide A 
were clustered (-pbc cluster) in the respective frame. Finally, only the actin protein was centered in the 
box and all ATP, irio3a/redA movement was to happen in respect to the centered protein (-center).  
Finally, all trajectories were concatenated into a single trajectory via trjcat -cat module implemented in 
GROMACS.  
The distances of iriomoteolide with every residue of actin as well as other iriomoteolide molecules in 
the same box were calculated via g_dist in GROMACS. For iriomoteolide, reidispongiolide A, and the 
respective residue, the centers of mass (COM) were considered for evaluation of distances. Contact 
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frequencies for each residue were calculated by evaluating if the center of mass distances between 
irio3a/redA and each residue was equal and lower than 1 nm. If the threshold was crossed each snapshot 
would be registered with a binary value of 1. For the simulations containing 10 iriomoteolides, all irio3a 
copies were considered per residue. If the threshold was not crossed the snapshot would be registered 
with 0. The relative contact frequency (RCF) for each residue for the given iriomoteolide simulations 
(5x700 ns, single iriomoteolide; 25x100 ns, single iriomoteolide; 10x100ns ten iriomoteolides) was then 
calculated by: 
 
( )1..n
i
i
NC =
max N
                                                               (9) 
 
where Ci is the contact frequency for residue i. Ni for each residues i is the number of snapshots for 
which the contact binary was set to 1. max(N1..n) is the largest Ni. All contact frequencies are thus 
annotated relative to the contact frequency of the “most visited” residue which has a RCF of 100%. Heat 
maps on the protein surfaces were then generated via Pymol by substituting the b-factor column with 
the relative contact frequencies and then applying a green/red color scheme where red is high contact 
frequency and green is low contact frequency19. 
 
5.2.3 Binding mode analysis: clustering and cut-based free energy 
profiles 
Prior to the cluster analysis and cut-based free energy profile (cFEP) generation all alpha carbons of G-
actin were aligned to the starting structure of the respective production runs for every snapshot87,88. 
Cluster analysis was performed using tree-based clustering included in CAMPARI, taking into accounts 
all 700 ns simulations for which iriomoteolide traversed the system to the barbed end of G-actin89,90. 
RMSD-based clustering was performed with threshold radius (CRADIUS) of 2.5 Å, a tree height 
(BIRCHHEIGHT) of 9 and a coarsest threshold (CMAXRAD) of 14 Å. This procedure was repeated for 
the combined simulations including the original 3 x 700 ns simulations plus 5 x 300 ns simulations 
which were elongated from the 25 x 100 ns simulations. The clustering was performed on all heavy 
atoms of iriomoteolide. Subsequent to clustering a cut-based free energy profile (cFEP) was generated 
in  WORDOM (version 0.22)91,92.  
The free energy profile was generated by deploying a method based on the equilibrium kinetic network 
which preserves the free energy barriers87,88,93. This methods emulates the cuts in flow-networks, and 
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the computed profile is therefore named cut-based free energy profile. The nodes and links of the 
equilibrium kinetic network are the clusters which were generated via the tree-based clustering as 
outlined above and the direct transitions between them sampled along the MD runs, respectively. For 
each node, all nodes are partitioned into two groups A and B by applying the mean first passage time 
(MFPT) to the reference node as an order parameter. The free energy is related to the maximum flow 
between sets A and B and calculated as G= −kT ln(ZAB/Z), where ZAB/Z is the relative partition function 
which represents the statistical weight of the transitions between sets A and B. The result is a one-
dimensional profile along the reaction coordinate ZA/Z (i.e., the relative partition function representing 
the statistical weight of set A) which preserves the barrier height between the free energy basins.  
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5.3 Results  
 
 
Figure 13: Overview of inter-iriomoteolide distances for the 10x100 ns simulations with an irio3a : actin ratio of 
10 : 1. a-i) Each color (purple, cyan, green, blue, black, red, brown, yellow, gray, magenta) shows the distance of 
the first iriomoteolide in the system with the remaining nine. Distance evaluations of other iriomoteolides were 
omitted as aggregation was considered severe already. Over the course of all simulations there is severe 
aggregation denoted by distances around 0.5 nm for more than 70 ns for several molecules. Center of mass 
distances were generated via g_dist implemented in GROMACS (v 3.3.6)  and plotted in GRACE (5.1.23, Evgeny 
Stambulchik)69. 
 
5.3.1 Simulations of high concentration iriomoteolide result in 
aggregation.  
Due to large size of monomeric actin and the resultant particles in the simulation exceeding 100,000, 
speeding up binding simulations was considered critical. The likelihood of interaction of a single 
iriomoteolide with actin is higher with increasing concentration of the ligand molecule. The box size 
chosen for the simulation and the 10 copies of iriomoteolide in the system resulted in a concentration of 
roughly 16 µM iriomoteolide. For simulations containing 10 simultaneous iriomoteolides with G-actin,  
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Figure 14: Distances of single iriomoteolides with Gly168 for the 5 x 700 ns simulations with an irio3a : actin 
ratio of 1 : 1.  Simulations 2-4 show center of mass distances between irio3a and Gly168 smaller than 1 nm after 
20 ns, 90 ns, and 170 ns respectively. Simulations 1 and 5 bind with a 2nd and 3rd interaction site after 120 ns and 
250 ns. Distances plotted in GRACE (5.1.23, Evgeny Stambulchik).  
 
a simple distance evaluation from one copy to the other was carried out. The analysis shows that at least 
two iriomoteolide were aggregated at some point in all simulations (Figure 13 a-i). The aggregates were 
characterized by the individual molecules being within a center of mass (COM) distance of 1 nm. It is 
important to point out that due to its size and the center of mass of iriomoteolide is roughly 0.5 nm from 
its outmost atoms. The shown aggregates remained on average for 10 ns before one iriomoteolide moved 
away and associated with different iriomoteolide molecules or the same cluster would be formed again.  
 
5.3.2 High-concentration iriomoteolide simulations show that there 
are three hotspots of association with the actin monomer.  
The primary site of interaction is around residue Met227 (Figure 15c, Supplementary table 1) with the 
largest relative contact frequency of 100 %. This hot spot of interaction with iriomoteolide extends up 
to 5 adjacent residues (upstream and downstream). A secondary and tertiary site of association were 
observed at residues Met283 and Gly168 respectively. High relative contact frequency values for  
 142 
 
 
Figure 15: Summary view of the relative contact frequencies for all actin iriomoteolide simulation schemes. a-
c) Heat map of relative contact frequencies for the three distinct simulation schemes. Top and middle panel 
represent front and back of G-actin, the bottom panel shows a top-down view of the barbed end. a) and b) show 
high similarity in the distribution and intensity of the respective high contact residues, primarily in the barbed end. 
c) shows lower Ci values for the barbed end  and higher values for Met355. d) Annotation of axial/lateral contacts 
in F-actin with the adjacent monomers. The pointed end and the barbed end of the next monomer are interfaces 
where obstruction would lead to an effective sequestering of monomers.  
 
sequentially adjacent residues attributed to the same location on the protein. The fourth peak in contact 
frequency (64 %) around Phe352 is closely located at the barbed end near Gly168. However, given the 
observed aggregation of iriomoteolide molecules, these results were considered to be severely impacted 
by the aggregates. Aggregates interacting with actin would restrict the single-molecule interaction as 
the iriomoteolide closest to the actin would be influenced by the surrounding iriomoteolides. To evaluate 
iriomoteolide binding behavior without aggregates, single-iriomoteolide simulations of different lengths 
were subsequently run. 
 
5.3.3 Single-iriomoteolide simulations indicate preferred 
interactions with the barbed end of monomeric actin.  
To analyze interactions of iriomoteolide with G-Actin without eventual effects of aggregation a 1:1 ratio 
simulation of iriomoteolide 3a and actin was chosen. A total of 30 simulations were conducted out of 
which 5 simulations were run for 700 ns, 25 simulations for 100 ns of which 5 were extended to 300 ns 
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resulting in a cumulative simulation time of 7 µs. The 5x700 ns simulations initially run, were evaluated 
for the distance of iriomoteolide with Gly168, a central residue of the barbed end. The distance analysis 
showed that out of the five simulations with different positions of iriomoteolide within the box, three 
(Figure 14) show binding of irio3a to the barbed end of actin within 20 ns, 90 ns, and 170 ns respectively. 
All three irio3a molecules started from a distance to the barbed end which exceeded 4 nm. Subsequently, 
all three iriomoteolide molecules remained close to Gly168 for the remaining simulation time with 
distances fluctuating around 1 nm. Simulation 1 (Figure 14 black), for which no association to the barbed 
end was observed, indicated that for the first 110 ns of the simulation the iriomoteolide traverses the 
system with no fixed residence. Indicative for unobstructed movement through the system is the high 
fluctuation of distances within a short period of time. Following the 110 ns mark, the iriomoteolide 
remained at ~ 2.5 nm distance of Gly168 and stayed in place in relative stability until 650 ns. After fast 
dissociation, irio3a stably re-associated with the protein at a relative distance of 3 nm for the remainder 
of the simulation. In simulation 5 (Figure 14 yellow) the iriomoteolide moved away from Gly168 within 
the first 100 ns. Afterwards it showed high fluctuation of distances indicating repetitive movement over 
the periodic boundary of the system box. Following the 250 ns mark, this irio3a associated with actin 
and remains stable until 475 ns after which it entered a period of binding and rebinding events indicated 
by fast transitions between distances between 4.0 and 4.5 nm. This behavior continued until the end of 
the simulation indicating a site of weaker binding than for the barbed end in simulations 2-4 and 
simulation 1 (Figure 14 red, green, blue). 
To further evaluate all residues for possible interactions with iriomoteolide a heat map displaying all 
contact frequencies was generated for the 5x700 ns and 25x100 ns simulations (Figure 15 a,b; 
Supplementary Table 2,3). The relative contact frequencies show a significant hot spot for interaction 
at the barbed end with Phe352 (Ci of 100%) representing the residue for which most of the interaction 
with iriomoteolide was observed. Secondary hot spots indicative for preferred interaction, albeit very 
weak in comparison, were located at Met227 and Met283. These sites of interaction are identical to the 
simulations with an iriomoteolide-to-actin-ratio of 10:1 however they differ in magnitude of the relative 
contact frequencies. For the 1:1 ratio simulation, the barbed end was the actin region of highest contact 
frequency while in the 10:1 ratio simulation this hotspot had the lowest relative contact frequencies 
(Figure 15a,c). Sites Met227 and Met283 displayed comparatively lower contact  
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Figure 16: Summary of relative contact frequencies per residue of the individual simulation schemes, annotated 
only for residues identified to be in contact with adjacent monomers according to the Oda et al. 2009 model26. 
Blue dots show axial contacts (Figure 15d, black), red indicates lateral contacts (Figure 15d, white), and green 
indicates both axial and lateral contacts (Figure 15d, gray). a) Results for the 5 x 700 ns simulation show the 
highest contact frequencies (above 70 %) for residues involved in axial contacts. b) Ci profile for 25 x 100 ns 
simulations. Both single-iriomoteolide simulations schemes show very similar results indicating sufficient 
sampling. c) The Ci for the 10 copy iriomoteolide simulations show higher average contact frequencies for more 
residues which is likely caused by prolonged residue times per any of the iriomoteolide upon aggregation. The 
residues with the highest relative contact frequency are not shown however as Met283 and Met227 are not involved 
in inter-actin-interaction in F-actin. 
 
frequencies in the 1:1 ratio simulations compared to the 10:1 simulations. Both simulation schemes 
showed very low contact frequencies outside of the observed hot spots. Overall the results indicated that 
the system was sufficiently equilibrated and that the barbed end represented the site of preferred 
interaction of iriomoteolide with actin. 
 
5.3.4 Iriomoteolide at the barbed end would obstruct the interface 
of axial assembly of actin monomers.  
The barbed end of monomeric actin is the interface for axial and lateral association in in the nucleation  
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Figure 17: Cut-based free energy profiles and sampling frequency of the two major free energy basins. a) cFEP 
for the with the largest cluster being the target reveals two basins which are separated by a barrier of 6.4 kcal/mol. 
Cluster 3 is located within the second basin. b) cFEP with cluster 3 as the target. Similarly, this cFEP shows two 
free energy basins separated by a 6.5 kcal/mol energy barrier.  c) Basin progression over all 5 x 700 ns. Although 
basin 2 was sampled in two out of the three simulations where iriomoteolide bound to the barbed end basin 1 was 
sampled more often within the simulation. 
 
and polymerization of actin. It is an interface for a total of three actin monomers, n, n+1, n+2. A 
comparison of all heat maps with residues defined as being in contact with other actin monomers in F-
actin (Figure 15 c,d) showed that out of the three hotspots identified the barbed end hotspot is the only 
one which would primarily interfere with  association of G-actin subunits into nuclei or actin fibers26. 
This is further supplemented other natural productions being shown to bind to the barbed end, displaying 
inhibition of actin polymerization/nucleation27. Both lateral and axial interaction of one monomer with 
adjacent monomers would be obstructed by an iriomoteolide molecule binding inside the barbed end 
with high affinity. The second site of interaction, around Met283, is located outside the barbed end in 
subdomain 1 which features axial contacts with other actin monomers. Interaction site Met227 is on the 
periphery of several lateral contacts between actin monomers but featured no direct  
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Figure 18: Time series of RMSDs of basin representatives from the 5 x 700 ns simulations for the 25 x 100 ns 
simulations. a) The analysis showed that in 25 simulations conformations close to the basin representatives 
(threshold of 5 Å, green line) were simulated five times. Within these five simulations basin 1 (black) and 2 (red) 
were sampled two and three times respectively. b) Extension of the five 100 ns simulations to 300 ns simulations 
revealed that three simulations kept sampling the basin for the entirety of the simulation while one simulation (1st 
column) exchanged the basin from 1 to 2. One simulation (2nd column) kept sampling iriomoteolide conformations 
slightly outside the threshold chosen but was none the less included in the later binding mode evaluation. 
 
interaction with either. Thus, this hotspot was considered the least likely to interfere with nucleation or 
polymerization of actin given the Oda et al. 2009 model26. An analysis for residues only involved in 
inter-actin interaction showed high similarities between 25x100 ns simulations and 5x700 ns simulations 
(Figure 17a,b). Residues Leu346, Thr351 and Gly168 represent the residues with the highest contact 
frequencies above 70 %. All of these residues are located in the barbed end. Compared to the 10x100 ns 
simulations with 10 copies iriomoteolide those residues in the barbed end displayed a higher contact 
frequency. As previously shown the 10x100 ns simulations featured relatively higher contact 
frequencies for any residues including the ones interacting with n+1 and n+2 actin (Figure 16c). 
Additionally, this data showed clearly that the global maximum Met227 would not feature interference 
with actin nucleation/polymerization. 
 
 147 
 
 
Figure 19: Cut-based free energy profiles for the supplemented simulations. a,b) Both cFEP plots show two 
basins separated between a 5.5 kcal/mol barrier. However the two largest clusters are now distributed distinctly 
between the basins.  
 
5.3.5 Cluster- and cut-based free energy profile analysis revealed 
two distinct basins.  
In order to identify possible binding modes for three 700 ns simulations in which iriomoteolide moved 
to the barbed end, a cluster analysis was conducted (Supplementary table 4). Deploying the tree-based 
clustering algorithm (developed by Vitalis et al. 2012 and implemented in CAMPARI) with a 
subsequent cut-based free energy profile analysis via the mean first passage time (MFPT) method, two 
free energy basins were identified (Figure 17 a,b). These basins are separated by an energy barrier 6.5 
kcal/mol. Several small minima are located along this barrier but were neglected for further analysis. 
The three largest clusters of the clustering are located in these two basins. Interestingly, the two largest 
cluster (cluster 1: 11634 members, cluster 2: 8414 members) were located in the same basin. Behavior 
like this is indicative of a small kinetic distance between the respective clusters based the conformations 
sampled. It was projected that if the clustering cut-off (2.5 Å) was increased, clusters 1 and 2 would 
become a single cluster. The 3rd largest cluster is located in the second basin separated by the free energy 
barrier (7,444 members). To investigate if transitions between the two energy basins occurred, cluster 
progression analysis of clusters 1 (basin 1) and cluster 3 (basin 2) for the three simulations where 
iriomoteolide bound to the barbed end was generated. Basin 2 was sampled in two out of three 
simulations while basin 1 was sampled in a single simulation thus, no transition between basins within 
the respective simulation was recorded (Figure 17c). This was deemed indicative of the  
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Figure 20: Cluster progression for the supplemented simulations. The results show that cluster 2 was simulated 
in 6 simulations while cluster 1 was simulated in 2 simulations. However, overall cluster 1 was sampled more 
often within the respective simulations indicating that this binding mode, once sampled, was more stable. 
 
simulation data not being sufficient enough to derive exact binding pose prediction. To supplement the 
simulation data, RMSD evaluation for the representative clusters of the basins were performed for all 
25x100 ns simulations. For five simulations a threshold of 0.5 nm was crossed showing that structures 
closely resembling the respective clusters were sampled (Figure 18 a). Three simulations sampled 
conformers closely similar to the representative of basin 2 with a RMSD being as low as 2.5 Å. In three 
simulations iriomoteolide conformations highly similar to representative of basin 1 were sampled out of 
which two were taken for extended sampling (Figure 18b). All chosen simulations were then extended 
to 300 ns at the end of the study. All extended simulations showed RMSD values below the threshold 
of 5 Å and where thus incorporated into the second generation of binding mode determination. 
 
5.3.6 Supplemented simulations show two binding modes at the 
barbed end.  
The evaluation of the tree-based clustering and subsequent cFEP for the combined simulation lead to a 
similar picture as the initial 3x700 ns simulations. Two distinct basins were identified separated by a 
barrier with 5.5 kcal/mol and several local minima in between. The barrier height was independent of  
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Figure 21: Cluster representatives of the two free energy basins sampled upon binding of iriomoteolide at the 
barbed end of monomeric G-actin. a, c) Cluster 1 was the largest cluster and the cluster representative shows a 
binding mode similar to natural products like reidispongiolide A. The hydrophobic tail is inserted into the barbed 
and the macrocycle is located along the hydrophobic patch. b, d) The representative of cluster 2 shows a similar 
arrangement of the hydrophobic tail while contrary to cluster 1 the macrolide resides on top of the tail section and 
not along the hydrophobic patch of the barbed end periphery. Images rendered in Pymol19.  
 
the chosen target cluster indicating robustness of the cFEP (Figure 19 a,b). A major difference between 
the original analyses and the supplemented one is that the two largest clusters are now in different basins. 
Interestingly, as with the 3x700 ns simulations the 2nd generation analysis shows that the largest cluster 
was sampled in fewer simulations (1x700 ns + 1x300 ns) but with higher total number of cluster 
members indicating higher stability of the system once the conformation is reached (Figure 21). Cluster 
2 was sampled in more simulations (4x300 ns + 2x700 ns) but with overall less members (Figure 20, 
Supplementary table 5) which is characteristic for less stable binding modes. This was further  
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Figure 22: Overview of structural behavior of reidispongiolide A in five 100 ns simulations. a) RSMD of all 
heavy atoms of redA with the X-ray coordinates as reference. The first simulation shows an increased RMSD up 
to 4.3 Å while all other simulations show the RMSD fluctuating around 1.5 Å. b) Superposition of the reference 
crystal structure (magenta sticks) and the snapshot with the largest RMSD of 4.3 Å (orange sticks). This snapshot 
shows the dissociation of the tail section out of the barbed end while the marcocycle remained in its position. The 
overall shift resulted from the alignment being performed on all α-carbons and their respective movement 
compared to the reference snapshot. Figure generated in Pymol19. 
 
supplemented by the cluster progression displaying a less solid lines for cluster 2 compared to cluster 1. 
In conjunction with iriomoteolide not dissociating from the barbed end after the initial binding has 
happened, these results strongly indicated that iriomoteolide might be able to adopt several 
conformations in the barbed end of monomeric actin and that the mode of binding and its relative 
stability are strongly dependent on the conformation upon binding. The three dimensional arrangement 
of the cluster representatives with actin, revealed a binding mode similar to other macrolide natural 
products (Figure 21 a-d, 10a-e). Both clusters show an overall similar interaction with the protein 
whereas hydrophobic tail interacted with hydrophobic residues in the barbed end and the macrocycle 
located on the periphery. The most prominent difference between cluster 1 and cluster 2 is that the macro 
cycle in cluster 2 is located above the tail in a more condensed conformation (Figure 21 a-d). Cluster 1 
represents a more stretched conformation with the macro cycle and hydrophobic tail providing a similar 
amount of interface with the barbed end. The closest residues (within 4.5 Å) of iriomoteolide with G-
actin in cluster 1 were Phe375, Met355, Phe352, Thr351, Leu349, Leu346, Ile345, Gly168, Thr148, 
Arg147, Gly146, Tyr143, Leu140, A1a35 and Tyr 133. No hydrogen bond  
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Figure 23:  Time series for 5 x 600 ns simulations of redA with G-actin started from a dissociated state. a) Four 
of five simulations show RMSD values larger than 10 Å. b) Close up of the RMSD values with a base line set at 
2.5 Å (orange line). Only a single simulation came close to sampling the crystal structure as observed in the 
simulations started from the crystal structure. All other simulations did not sample conformations with RMSD 
values below 10 Å. 
 
geometries were recorded for any residue and iriomoteolide. Cluster 2 interacts with residues Phe375, 
Met355, Thr351, Gly168, Thr148, Tyr143, Val139 and Tyr133 displaying overall less contacts with the 
tail being the primary contribution to interaction with G-actin with no hydrogen bonds formed. 
 
5.3.7 Simulations of bound reidispongiolide A support proposed 
mechanism of fibril disruption.  
Five simulations carried out for bound reidispongiolide A (PDB-id: 2ASN) showed that over 100 ns a 
total of four simulations show a RMSD fluctuating between 1.5 Å and 2.5 Å over the entire simulations. 
Within this range redA is in contact with Tyr133, Val139, Ser141, Tyr143, Ala144, Ser145, Gly146, 
Arg147, Thr148, Gly168, Tyr169, Ile330, Pro332, Glu334 and Ser338, Ile341, Ile344, Leu345, Leu349, 
thr351, Met355  (Figure 11b,c). A single simulation showed an increase of RMSD up to 4.3 Å for all 
heavy atoms of redA (Figure 22a). Closer inspection of the reidispongiolide A conformation at the 
largest RMSD showed that the tail section is actually removed from the barbed end while the macro 
cycle stayed in place (Figure 22b). Upon rearrangement of the tail, interaction with Tyr133, Val139, 
Gly168, Tyr169, Glu334, Met355 is lost. The return of the RMSD below 3 Å was indicative for the tail 
being reinserted into the barbed end. Albeit this behavior being sampled only a single time in five 
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simulations, it would support the proposed mechanism of the macro cycle providing the interface which 
interacts with G-actin first while the tail section is then inserted into the fibril severing it48. 
 
5.3.8 Binding simulations of redA do not reproduce crystal 
structure conformation on a 600 ns scale.  
To assess the ability of molecular dynamics simulations being able to recreate the crystal structure 
conformation of redA, five simulations for 600 ns were started with random positions of redA in the 
active site. Compared to the binding simulations of iriomoteolide binding to the barbed end only a single 
simulation resulted in redA associating with the barbed end of the actin monomer in a conformation 
closely resembling the crystal conformation (Figure 23 a,b). For this simulation the RMSD gradually 
lowers until after 470 ns an RMSD of 3 Å is reached. Simulation 2 shows fast association of the redA 
with G-actin at a position outside of the barbed end with a RMSD of 22 Å. For 450 ns this position is 
maintained until dissociation at 500 ns and re-association with G-Actin 50 ns later shown by significant 
fluctuation until an RMSD of 50 Å was reached until the end of the simulation. Contrary, simulation 3 
shows a redA being unbound for 30 ns after which an association event occurs and redA did not unbind 
from its site of interaction. Simulation 4 shows similar behavior with a dissociated phase being simulated 
for 230 ns after which it maintains a position different from the reference crystal structure conformation 
around 20 Å. Simulation 5 sampled redA for the longest period of time in an unbound state until at 450 
ns it binds to the monomer with an RMSD similar to simulation 3.  
The results show that the binding of redA to G-actin did not converge on a time scale of 600 ns. 
Compared to iriomoteolide binding to the barbed end was only observed in a single simulation for ~ 50 
ns while for iriomoteolide three simulations sampled the inhibitor 1.75 µs associated with the barbed 
end (Figure 15). Similarly to iriomoteolide, redA mostly remains at the individual binding sites after the 
initial binding has occurred.  
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5.4 Discussion 
 
In this study, the simulations of two naturally occurring macrolides iriomoteolide 3a and 
reidispongiolide A with G-actin were presented. Ten 100 ns binding simulations for an iriomoteolide to 
G-actin ratio of 10:1 showed high aggregation of iriomoteolide molecules in all simulations (Figure 13). 
Despite iriomoteolide providing three hydroxyl groups as well as an ester group and epoxide group, the 
propensity to aggregate in water resulted in at least three iriomoteolide molecules being closely 
associated (Figure 12a,13a-i). An interface for the aggregation of iriomoteolides with one another is 
most likely mediated by the hydrophobic tail of iriomoteolide as well as the aliphatic and methyl 
domains of the macro cycle. The aggregation of peptides into oligomers and lipids into micelles are 
processes well studied by molecular dynamics situation94–96. Given the accuracy of protein and lipid 
force fields to confidently model these such systems, it is unsurprising that iriomoteolide 3a would 
aggregate considering the large aliphatic tail section. However, iriomoteolide 3a provided three 
hydrogen bond donors and 6 hydrogen bond acceptors resulting in a total of 9 moieties for polar 
interaction with water. It is recommended to measure the in vitro aggregation of iriomoteolide 3a to 
reconcile the observation with the observed behavior in silico as it has been found out that aggregator 
molecules significantly influence polymerization of proteins97.  
The evaluation of contact frequencies showed a total of three hotspots of interaction surrounding the 
residues Phe352, Met283, and Met355 out of which Phe352 represented a central residue of the barbed 
end (Figure 15) close to Gly168. Binding of iriomoteolide to the barbed end of monomeric actin would 
provide the most plausible region of polymerization suppression as a multitude of other natural products 
interacts with the barbed end of actin27. However, considering the  number of aggregates, it was naturally 
assumed that the observed contact frequencies are influenced by aggregates artificially, increasing 
residence times of an iriomoteolide interacting with G-actin. 
To avoid artifacts in binding behavior, a series of simulations was carried out with an iriomoteolide to 
actin ratio of 1:1. Five simulations of 700 ns each showed three different sites of residence (Met283, 
Met355, Phe352) with the barbed end (and representative Phe352/Gly168) being the  prime interaction 
site which was sampled three times. Binding of iriomoteolide happened within 200 ns in all three cases 
and resulted in a cumulative residence time of 1.75 µs at the barbed end. Two simulations resulted in 
sampling of the secondary interaction sites around Met283 and Met355. These sites are identical to the 
high concentration iriomoteolide simulations. The main difference between the results is the magnitude 
of relative contact frequencies. While for the 10x100 ns simulations, involving 10 iriomoteolide 
molecules, Met355 was the site of highest contact frequency Phe352 was the residue of highest contact 
frequency for the 5x700 ns simulations (Supplementary Table 1,2). It is interesting to point out that in 
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both simulation schemes, the three sites of highest contact frequency are around the same residues giving 
some level of confidence to the observed interactions. Out of all three interaction sites the barbed end 
with Gly168 (close to Phe352) would represent the viable site for inhibiting G-actin polymerization. 
Several crystal structures for natural product macrolides have already shown that these molecules bind 
at the barbed end while having in vitro properties that lead to the sequestering of monomers, fibril 
disruption and polymerization inhibition47–51. To asses if the system was equilibrated a series of 25 
simulations was run for 100 ns and 5 different positions of iriomoteolide in the box. These simulation 
show a very similar behavior of iriomoteolide associating with G-actin. Identical to the previous two 
simulation schemes, it was observed that three primary interaction hotspots are around residues Gly168, 
Met283, and Met355. The combined total of 5.6 µs in which interaction with the barbed end was sampled 
the most frequent and the three primary interaction sites being identical, indicated an equilibrated system 
which shows that iriomoteolide binds preferably at the barbed end. 
Finally, it is worthwhile highlighting that upon binding towards the barbed end iriomoteolide did not 
dissociate for the remainder of the respective simulation which lead to further confidence that the barbed 
end is the prime site of actin polymerization inhibition by iriomoteolide.  
To obtain further structural insight into the specific interaction of iriomoteolide with the barbed end all 
simulations where binding of iriomoteolide to the barbed end was observed were extended to simulations 
exceeding 500 ns each to a combined total of 1.75 µs. Iriomoteolide was then clustered and a cut-based 
free energy profile was generated to assess conformations upon binding. The cut-based free energy 
profile for the combined simulations revealed two distinct basins showing two distinct modes of binding. 
Both are similar in their relative arrangement with the hydrophobic tail being inserted into the barbed 
end interacting with its hydrophobic patch while the macro cycle is located either on top of the tail in 
what is considered a condensed conformation. An extended conformation is characterized by the 
macrocycle being located on the periphery of the barbed end similar to macrolides like reidispongiolide 
A and trisoxasoles47.  
Out of the two conformations, the extended conformation was more stable but occurring in less 
simulations while the condensed conformation occurred in more simulations but was less often sampled 
(Figure 20). From this data, at least two possible modes of interaction could be assumed as no transition 
from one binding mode to the other was observed in the simulation. A comparison the binding modes 
with X-ray crystallography data from reidispongiolide A bound to G-actin showed that the extended 
conformation is the one closer to redA and other natural products as the number of residues which are 
located within 4 Å of irio3a and redA is high for the extended conformation. Finally, the author suggests 
that in order to fully validate the findings presented here, NMR spectroscopy or X-ray crystallography 
should be carried out. 
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The simulations of bound reidispongiolide A suggest that the binding of the macrocycle is stronger than 
the hydrophobic tail. The single observed tail dissociation would support the mode of interaction as 
proposed by Allingham et al. 2005 whereas the macrocycle interacts first with the fiber and then inserts 
the tail into the barbed end, severing the filament48. Binding simulations of reidispongiolide A were not 
able to sufficiently reproduce the crystal structure indicating the need for extended simulations. None 
of the 5 simulations of unbound redA was able to generate binding behavior similar to the simulations 
of bound reidispongiolide A. 
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5.6 Supplementary material  
 
 
Table 1: Relative contact frequencies (Ci) for all residues of the 10x100 ns scheme with a irio3a to actin 
ratio of 10 : 1. All residues having a Ci of 0 % were omitted.  
 
 
 
 
 
 
 
 
residue residue residue residue residue residue residue residue residue
6THR 40 58ALA 2 98PRO 3 147ARG 21 196ARG 17 234SER 5 272ALA 12 317ILE 10 354GLN 43
7ALA 33 59GLN 12 99GLU 5 148THR 48 197GLY 17 235SER 7 273GLY 4 318THR 23 355MET 60
19ALA 1 60SER 14 100GLU 10 149THR 3 198TYR 4 236LEU 10 275HSD 10 319ALA 19 356TRP 29
20GLY 4 61LYS 9 101HSD 19 161HSD 1 199SER 21 237GLU 3 276GLU 30 320LEU 36 357ILE 1
21PHE 17 62ARG 24 102PRO 30 165ILE 1 200PHE 10 238LYS 6 277THR 19 321ALA 35 358THR 17
22ALA 16 63GLY 19 109PRO 19 166TYR 7 201VAL 36 239SER 6 278THR 5 322PRO 46 359LYS 5
23GLY 16 64ILE 10 110LEU 35 167GLU 50 202THR 34 240TYR 3 279TYR 41 323SER 18 360GLN 6
24ASP 17 65LEU 2 111ASN 23 168GLY 73 203THR 35 241GLU 2 280ASN 63 324THR 30 361GLU 3
25ASP 6 66THR 11 112PRO 29 169TYR 58 204ALA 21 242LEU 1 281SER 14 325MET 39 362TYR 1
26ALA 5 67LEU 8 113LYS 16 170ALA 17 205GLU 9 243PRO 7 282ILE 10 326LYS 22 363ASP 1
27PRO 5 68LYS 5 114ALA 6 171LEU 5 206ARG 14 244ASP 2 283MET 81 327ILE 13 364GLU 5
28ARG 15 69TYR 5 115ASN 5 172PRO 33 207GLU 8 245GLY 2 284LYS 44 328LYS 16 365ALA 9
29ALA 5 72GLU 4 116ARG 1 173HSD 37 208ILE 6 246GLN 3 285CYS 6 329ILE 9 366GLY 4
30VAL 3 73HIM 6 117GLU 1 174ALA 19 210ARG 1 247VAL 2 286ASP 7 330ILE 3 367PRO 2
37ARG 4 74GLY 2 118LYS 2 175ILE 32 211ASP 2 248ILE 1 287ILE 30 331ALA 3 368SER 10
38PRO 8 75ILE 6 121GLN 1 176MET 28 214GLU 1 249THR 2 288ASP 9 332PRO 6 369ILE 9
39ARG 9 76ILE 3 125GLU 1 177ARG 20 215LYS 6 251GLY 12 289ILE 1 333PRO 4 370VAL 4
40HSD 9 77THR 4 126THR 3 178LEU 4 216LEU 6 252ASN 48 290ARG 30 334GLU 2 371HSD 17
41GLN 13 78ASN 1 127PHE 3 179ASP 8 217CYS 3 253GLU 14 291LYS 16 337TYR 1 372ARG 32
42GLY 15 79TRP 1 128ASN 1 180LEU 5 218TYR 5 254ARG 4 292ASP 5 338SER 1 373LYS 34
43VAL 16 80ASP 1 129VAL 2 181ALA 1 221LEU 6 255PHE 5 294TYR 11 341ILE 7 374CYS 24
44MET 13 83GLU 3 130PRO 24 183ARG 3 222ASP 5 256ARG 52 295ALA 4 342GLY 16 375PHE 49
45VAL 12 84LYS 4 131ALA 29 184ASP 8 223PHE 56 259GLU 5 296ASN 3 343GLY 3
46GLY 15 87HSD 23 133TYR 5 186THR 4 224GLU 75 260THR 1 305MET 1 344SER 7
47MET 15 88HSD 8 135ALA 3 187ASP 18 225ASN 26 263GLN 14 306TYR 1 345ILE 35
48GLY 16 90PHE 2 136ILE 4 188TYR 11 226GLU 2 264PRO 4 307PRO 5 346LEU 45
49GLN 14 91TYR 40 139VAL 20 189LEU 0 227MET 100 265SER 30 308GLY 1 347ALA 19
50LYS 10 92ASN 30 140LEU 11 190MET 16 228ALA 80 266PHE 48 310ALA 3 348SER 20
51ASP 13 93GLU 4 142LEU 17 191LYS 32 229THR 23 267ILE 26 311ASP 15 349LEU 51
52SER 6 94LEU 8 143TYR 55 192ILE 11 230ALA 43 268GLY 27 312ARG 1 350SER 21
53TYR 3 95ARG 40 144ALA 21 193LEU 1 231ALA 77 269MET 20 314GLN 20 351THR 63
56ASP 3 96VAL 31 145SER 11 194THR 31 232SER 37 270GLU 11 315LYS 22 352PHE 64
57GLU 1 97ALA 27 146GLY 38 195GLU 30 233SER 8 271SER 9 316GLU 6 353GLN 34
        
 163 
 
 
Table 2: Relative contact frequencies (Ci) for residues of the 5x700 ns scheme with a irio3a to actin ratio 
of 1 : 1. All residues having a Ci of 0 % were omitted.  
 
 
 
 
 
residue residue residue residue residue
6THR 23 94LEU 1 197GLY 1 283MET 2 354GLN 39
7ALA 23 95ARG 1 198TYR 1 284LYS 1 355MET 72
16LEU 1 96VAL 1 199SER 1 287ILE 1 356TRP 28
18LYS 1 100GLU 12 201VAL 2 290ARG 2 357ILE 1
20GLY 1 101HIS 18 202THR 1 291LYS 1 358THR 24
21PHE 1 102PRO 28 203THR 1 294TYR 1 359LYS 3
22ALA 1 103THR 1 206ARG 1 311ASP 1 360GLN 3
23GLY 1 129VAL 4 221LEU 1 314GLN 1 361GLU 2
24ASP 1 130PRO 25 222ASP 1 315LYS 2 364GLU 1
26ALA 1 131ALA 28 223PHE 24 318THR 1 372ARG 2
27PRO 2 133TYR 13 224GLU 24 319ALA 1 373LYS 19
28ARG 3 135ALA 1 225ASN 2 320LEU 1 374CYS 12
29ALA 2 136ILE 1 226GLU 1 321ALA 1 375PHE 53
30VAL 2 139VAL 61 227MET 27 322PRO 2
39ARG 2 140LEU 29 228ALA 17 323SER 1
40HIS 3 142LEU 27 229THR 3 324THR 1
41GLN 1 143TYR 76 230ALA 13 325MET 2
42GLY 2 144ALA 13 231ALA 15 326LYS 1
43VAL 3 146GLY 27 232SER 3 327ILE 1
44MET 2 147ARG 3 246GLN 1 336LYS 1
45VAL 3 148THR 76 247VAL 1 337TYR 1
46GLY 3 149THR 2 252ASN 16 342GLY 23
47MET 3 165ILE 1 255PHE 5 343GLY 2
48GLY 2 167GLU 58 256ARG 22 345ILE 28
49GLN 1 168GLY 98 259GLU 7 346LEU 90
61LYS 1 169TYR 63 263GLN 7 347ALA 15
63GLY 2 170ALA 1 265SER 7 348SER 4
64ILE 3 187ASP 1 266PHE 16 349LEU 60
65LEU 1 190MET 1 276GLU 1 350SER 11
66THR 1 191LYS 1 279TYR 2 351THR 92
67LEU 1 194THR 1 280ASN 2 352PHE 100
68LYS 1 195GLU 1 282ILE 1 353GLN 29
    
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Table 3: Relative contact frequencies (Ci) for residues of the 25x100 ns scheme with a irio3a to actin 
ratio of 1 : 1. All residues having a Ci of 0 % were omitted.  
 
 
 
residue residue residue residue residue residue
36GLY 1 115ASN 5 197GLY 19 250ILE 1 315LYS 29 367PRO 1
37ARG 3 117GLU 1 198TYR 11 251GLY 3 316GLU 2 368SER 6
38PRO 7 118LYS 1 199SER 17 252ASN 21 318THR 26 369ILE 7
39ARG 19 124PHE 3 200PHE 5 253GLU 3 319ALA 12 371HSD 1
40HSD 18 125GLU 2 201VAL 16 255PHE 3 320LEU 28 372ARG 9
41GLN 5 128ASN 5 202THR 10 256ARG 24 321ALA 26 373LYS 35
42GLY 7 133TYR 32 203THR 4 259GLU 2 322PRO 29 374CYS 22
43VAL 14 135ALA 6 204ALA 3 263GLN 5 323SER 8 375PHE 74
44MET 7 136ILE 10 205GLU 3 265SER 7 324THR 8
45VAL 22 139VAL 55 206ARG 2 266PHE 11 325MET 17
46GLY 27 140LEU 23 221LEU 17 270GLU 1 326LYS 11
47MET 24 142LEU 5 222ASP 9 271SER 3 327ILE 11
48GLY 15 143TYR 53 223PHE 28 272ALA 6 328LYS 3
49GLN 8 148THR 56 224GLU 39 276GLU 10 329ILE 1
60SER 6 149THR 3 225ASN 14 277THR 7 345ILE 1
61LYS 17 165ILE 7 226GLU 1 279TYR 35 346LEU 80
63GLY 19 166TYR 2 227MET 47 280ASN 41 349LEU 35
64ILE 29 167GLU 62 228ALA 39 281SER 7 350SER 7
65LEU 11 168GLY 98 229THR 9 282ILE 13 351THR 83
66THR 4 169TYR 77 230ALA 20 283MET 43 352PHE 100
67LEU 2 170ALA 8 231ALA 28 284LYS 17 353GLN 1
68LYS 2 173HSD 1 232SER 13 286ASP 1 354GLN 29
72GLU 2 174ALA 4 233SER 2 287ILE 7 355MET 90
73HIM 2 175ILE 3 234SER 1 288ASP 2 356TRP 7
75ILE 3 176MET 9 235SER 1 290ARG 17 358THR 3
77THR 4 177ARG 4 237GLU 1 291LYS 2 359LYS 7
78ASN 1 178LEU 1 242LEU 4 292ASP 1 360GLN 10
79TRP 1 187ASP 4 244ASP 3 294TYR 6 361GLU 9
110LEU 2 190MET 7 245GLY 6 308GLY 1 362TYR 4
111ASN 2 191LYS 10 246GLN 11 310ALA 2 363ASP 7
112PRO 6 194THR 15 247VAL 10 311ASP 21 364GLU 10
113LYS 1 195GLU 8 248ILE 8 312ARG 1 365ALA 9
114ALA 4 196ARG 6 249THR 4 314GLN 24 366GLY 4
     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Table 4: Tree-based clustering results for the 3x700 ns simulations.  
 
 
Table 5: Tree-based clustering results for the combined 3x700 ns + 5 x 300 ns simulations 
 
 
# No. Center Diameter Radius
1 11634 123700 1.6681 1.1795
2 8414 103019 1.7713 1.2524
3 7444 39318 1.6487 1.1658
4 5198 112710 1.7623 1.246
5 5046 40788 1.5572 1.101
6 4562 28274 1.9498 1.3786
7 4131 136242 1.5732 1.1123
8 3651 206680 1.6021 1.1327
9 3040 177933 1.6171 1.1433
10 2715 96779 1.7415 1.2312
# No. Center Diameter Radius
1 11921 102759 1.5711 1.1109
2 9158 39318 1.6321 1.154
3 7242 310176 1.7423 1.2319
4 6651 350726 1.5256 1.0787
5 5795 136949 1.5803 1.1173
6 5762 244005 1.8068 1.2775
7 5089 309459 1.7628 1.2464
8 4967 264312 1.6562 1.171
9 4965 177933 1.5657 1.107
10 4461 124049 1.7342 1.2262
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title       = Protein-ligand  
integrator  = md         
nsteps      = 50000000  
dt          = 0.002   
; Output control 
nstxout     = 0000 
nstvout     = 0000 
nstenergy   = 0000 
nstlog      = 5000 
nstxtcout   = 5000 
energygrps  = Protein ATP IRIO 
; Bond parameters 
continuation    = no   
constraint_algorithm = lincs 
constraints     = hbonds 
lincs_iter      = 1      
lincs_order     = 4  
; Neighborsearching 
ns_type     = grid 
nstlist     = 5 
rlist       = 1.0 
;Van der Walls 
vdwtype     = Cut-Off 
rvdw        = 1.0 
; Electrostatics 
coulombtype     = PME 
rcoulomb = 1.0 
pme_order       = 4 
fourierspacing  = 0.12 
; Temperature coupling is on 
tcoupl      = V-rescale 
tc-grps     = Protein_ATP_IRIO Water_and_ions  
tau_t       = 0.1   0.1 
ref_t       = 310   310  
; Pressure coupling is on 
pcoupl      = Parrinello-Rahman 
pcoupltype  = isotropic 
tau_p       = 2.0 
ref_p       = 1.01325  
compressibility = 4.5e-5 
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; Periodic boundary conditions 
pbc         = xyz  
; Dispersion correction 
DispCorr    = EnerPres   
; Velocity generation 
gen_vel     = yes 
gen_seed    = -1 
gen_temp    = 310 
 
Example .mdp file for the production simulations as presented in this study.  
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Chapter 6  
Conclusions & outlook 
 
The thesis presents four projects. While the study of cavitands and actin/iriomoteolide 3a 
provided insights into experiments performed prior to computational modelling, the virtual 
screening on SMARCA4 and simulation of CYP3A4 guided subsequent experiments. 
Chapter 2 of this thesis highlighted the in silico characterization of resorcine[4]arene cavitands. 
It was shown that modeled cavitand dynamics highly correlated with experiments and provided 
pivotal insights explaining previous inconsistencies in experimentally observed cavitand 
dynamics1,2. Emulation of the FRET experiment by a simple Markov state model generated 
from molecular dynamics distance and κ² values resulted in highly correlated donor 
fluorescence decay and fluorescence anisotropy decay curves. The results and correlation of 
simulation and experiment provides motivation for future application of molecular dynamics 
simulation for the design and dynamics analysis of small- to medium-sized organic compounds. 
Simple model systems like the cavitands, with their few degrees of freedom (compared to 
proteins), could also be employed to analyze dye-dye effects such as quenching, which were 
not included in the Markov state-based emulation presented herein. Given the high sensitivity 
of donor decay rates close to the Förster radius of the BODIPY dye, it appears crucial to 
generate the full protein-dye construct when modeling such systems. However, modeling a 
mixed system requires compatible small molecule and protein force fields; as such, 
development of missing parameters for residues linked to FRET dyes is critical. 
Chapter 3 presented the characterization of cytochrome P450 3A4 (CYP3A4) in complex with 
carbamazepine (CBZ). The molecular dynamics simulations and subsequent clustering to 
obtain a putative carbamazepine binding mode guided mutational studies resulting in altered 
epoxidation kinetics for three mutants (A370V, A370L, S119A), one of which (A370V) 
displayed a significantly higher turnover rate at high CBZ concentrations. Another mutant 
(I369F) gave an increased turnover rate at low concentrations which are more consistent with 
generally prescribed doses of CBZ. The I369F CYP3A4 mutant was deemed most interesting 
for follow-up investigation by structural methods such as X-ray crystallography or NMR. In 
order to elucidate the cooperative behavior which was observed upon mutation, molecular 
dynamics simulations with two and more CBZ copies in the active site are indicative at best 
and should be subject to more rigorous simulation and evaluation by quantum mechanics-based 
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analysis. In one of the simulations involving two CBZ molecules, a single CBZ left the active 
site through a channel previously described by Williams et al. 20043. All suggested mutants 
showed increased ratios of ferric high-spin species, with S119A displaying the largest increase,  
emphasizing its critical role in substrate metabolism4–9.  
While chapter 3 presented the optimization of a protein towards a ligand, chapter 4 presents a 
more classical case of optimizing a library of ligands into a small set containing an active 
molecule against the SMARCA4 bromodomain. The virtual screening presented in chapter 4 
employed an ALTA scheme incorporating tethered docking with rDock10. By applying this 
simple yet established screening technique we were able to reduce a multimillion database to a 
feasible set which included a 20 µM hit compound featuring a trans-glycoluril- N-[(2-
hydroxyphenyl)methyleneamino]acetamide scaffold not previously reported as active on the 
SMARCA4 bromodomain. Next steps will include generating derivatives of this scaffold in 
order to assess the correctness of its putative binding mode, as well as optimizing this hit into 
a lead structure. X-ray crystallography of the protein complex with this scaffold is needed to 
confirm the binding mode. There is little evidence that bromodomains are specific to certain 
histone acetylation patterns. A specificity could be explained by combinatorial readout of 
multiple epigenetic marks11. Thus, considerations of the lack of specificity for acetylation 
patterns must be extended to future chemical probes and inhibitors, leading to high probability 
of cross-reactivity for any identified compound. Therefor it is highly recommended to perform 
a selectivity panel study to ensure that the herein presented compound is particularly active on 
SMARCA4.  
The molecular dynamics simulations performed with iriomoteolide 3a and its target actin which 
were presented in chapter 5, suggest that the most probable binding site of iriomoteolide 3a is 
the barbed end. A multitude of chemically similar natural products which interfere with natural 
actin polymerization, have been structurally determined to bind at the barbed end, providing 
high confidence for the observed interaction site12–15. Binding to the barbed end of the actin 
monomer could explain the reduced actin polymerization by a monomer-sequestering 
mechanism. However, as it was observed that the two most sampled modes of binding do not 
interchange, insufficient sampling may limit the deduction of a binding mode. The different 
orientations of the macro-cycle indicate no specific interaction with the actin monomer aside 
hydrophobic interaction of the iriomoteolide 3a tail and the hydrophobic patch in the barbed 
end of actin. As this conflicts with the mode of interaction of other natural products, X-ray 
crystallography experiments are recommended to elucidate the nature of the complex. 
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Aggregation of organic molecules has been studied in the context of protein aggregation and 
micelle formation with and without proteins16–18. The observed aggregation of iriomoteolide 3a 
molecules in a high-concentration solution is therefore unsurprising. Aggregation of small 
molecules has been a longstanding problem in experimental studies and an understanding of 
the propensity of iriomoteolide 3a to aggregate  is required in order to reconcile simulation with 
experiment19.  
Simulations with monomeric actin and  bound reidispongiolide A showed that the macrocycle 
remained stable over five 100 ns simulations while in a single simulation the tail section 
dissociated before being reinserted into the barbed end. This observation (albeit sampled only 
once in five simulations) would support a model of actin fiber severing by insertion of its tail 
section into the inter-monomer region of two actin monomers after association of the 
macrocycle with the barbed end periphery20. However, as the event of redA tail dissociation 
happened only a single time, more sampling time would be required. Additionally, as redA is 
acting on F-actin, experimentally observed structures with the monomer are only limited in 
scope when trying to elaborate the exact mechanism of altered actin polymerization dynamics 
via reidispongiolide A. 
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